Dermatitis due to substances taken internally

L12_INTERNALSUBSTANCEDERM

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L27 Hospital discharge: ICD-9 — 693 Hospital discharge: excluded ICD-10 — L27.2 Cause of death: ICD-10 — L27 Cause of death: ICD-9 — 693 Cause of death: excluded ICD-10 — L27.2 2 out of 7 registries used, show all original rules.	2313
4. Check minimum number of events None	2313
5. Include endpoints None	2313
6. Filter based on genotype QC (FinnGen only)	2251

Control definitions (FinnGen only)

Control exclude: L12_DERMATITISECZEMA

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF12
Parent code in ICD-10: L20-L30
Name in latin: Dermatitis e substantiis devoratis

NAME	L12_INTERNALSUBSTANCEDERM
CONTROL_EXCLUDE	L12_DERMATITISECZEMA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L27
HD_ICD_9	693
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL	L272
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L27
COD_ICD_9	693
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL	L272
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Dermatitis due to substances taken internally based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2251	1437	814
Unadjusted period prevalence (%)	0.46	0.51	0.37
Median age at first event (years)	53.07	49.95	58.58

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2313: Matched controls
23130

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

XQ802

NOMESCO Finland

Epicutan test

29.9

307.7

225

L27.1

ICD-10 Finland

Localized skin eruption due to drugs and medicaments

280.9

307.7

434

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

1288.0

307.7

1544

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

10.0

307.7

543

686

XQ800

NOMESCO Finland

Prick test

8.0

263.7

394

577

L30.9

ICD-10 Finland

Dermatitis, unspecified

5.2

256.1

667

1674

H02AB06

ATC

prednisolone; systemic

4.1

233.9

1516

7303

L20.0

ICD-10 Finland

Besnier prurigo

+∞

232.3

219

E0000UV, ,

ATC

3.4

180.5

1223

5762

D07AB08

ATC

desonide; topical

5.2

173.4

407

915

XQ820

NOMESCO Finland

Exposure to medicinal substance

46.0

164.4

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

5.5

163.2

354

741

D07AC01

ATC

betamethasone; topical

3.2

161.5

1014

4495

R06AE07

ATC

cetirizine; oral

3.0

145.6

1315

7042

6930B

ICD-9 Finland

Dermatitis due to substances taken internally, Due to drugs and medicines[EXANTHEMA EX USU PHARMACIS]

+∞

144.3

137

D07AA02

ATC

hydrocortisone; topical

3.8

128.4

472

1474

XQ899

NOMESCO Finland

Other assessment of skin

43.0

125.2

L50.0

ICD-10 Finland

Allergic urticaria

8.1

124.6

174

231

J01FF01

ATC

clindamycin; systemic

2.9

116.9

817

3715

T78.4

ICD-10 Finland

Allergy, unspecified

5.8

112.3

219

412

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

+∞

107.1

102

E000001, ,

ATC

3.0

105.7

585

2326

D07AB02

ATC

hydrocortisone butyrate; topical

2.7

104.0

790

3712

XQ801

NOMESCO Finland

Intracutantest

26.7

101.6

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

7.9

94.3

133

178

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.4

94.3

1185

6976

C01CA24

ATC

epinephrine; parenteral

4.3

93.5

258

649

TQW80

NOMESCO Finland

Local dermatologic skincare

10.5

92.3

103

102

L27.2

ICD-10 Finland

Dermatitis due to ingested food

913.1

90.4

R50.9

ICD-10 Finland

Fever, unspecified

3.0

90.0

498

1963

D07BA04

ATC

hydrocortisone and antiseptics; topical

3.6

90.0

330

1015

501

Kela drug reimbursment

Cow's milk and / or soy protein allergy in young children

15.0

82.1

L50.9

ICD-10 Finland

Urticaria, unspecified

5.3

82.1

172

344

D07AC13

ATC

mometasone; topical

2.5

80.8

707

3485

6939X

ICD-9 Finland

Dermatitis due to substances taken internally, Due to unspecified substance taken internally

+∞

78.6

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

8.1

75.2

103

133

E000002, ,

ATC

3.3

73.3

310

1038

D02AX

ATC

Other emollients and protectives

6.7

70.2

114

178

6931A

ICD-9 Finland

Dermatitis due to substances taken internally, Due to food

+∞

70.2

D07AD01

ATC

clobetasol; topical

2.8

68.6

416

1702

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

3.0

68.1

350

1310

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.0

67.0

331

1211

L27.9

ICD-10 Finland

Dermatitis due to unspecified substance taken internally

+∞

63.8

L30.3

ICD-10 Finland

Infective dermatitis

8.9

62.6

J01MA12

ATC

levofloxacin; systemic

2.5

61.5

490

2279

317

Kela drug reimbursment

Topical pimecrolimus and tacrolimus

+∞

59.6

L20

ICD-10 Finland

Atopic dermatitis

+∞

59.6

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

4.4

58.5

155

375

E000006, ,

ATC

3.7

57.9

197

571

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.1

56.8

825

4882

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.6

55.0

382

1659

A46

ICD-10 Finland

Erysipelas

2.6

54.2

364

1555

J01MA02

ATC

ciprofloxacin; systemic

2.0

52.4

914

5734

H02AB04

ATC

methylprednisolone; systemic

2.5

51.9

380

1690

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.1

51.6

702

4027

R06AX27

ATC

desloratadine; oral

2.1

51.5

725

4210

E000003, ,

ATC

4.4

50.8

130

306

6918B

ICD-9 Finland

Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[ECZEMA ATOPICUM]

+∞

50.2

L04AX03

ATC

methotrexate; systemic

2.8

49.9

287

1132

L04AX01

ATC

azathioprine; systemic

4.0

49.7

149

395

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.9

49.0

151

408

ZX108

NOMESCO Finland

Inhalation

12.2

48.0

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.6

47.5

320

1365

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.6

47.1

302

1257

H02AB07

ATC

prednisone; oral

2.4

46.9

360

1631

N05BB01

ATC

hydroxyzine; systemic

3.3

45.5

183

589

A02BC02

ATC

pantoprazole; systemic

1.9

45.3

1534

11747

R06AE09

ATC

levocetirizine; oral

2.3

44.0

376

1782

N02AX02

ATC

tramadol; systemic, rectal

1.9

43.4

965

6450

J01DB01

ATC

cefalexin; oral

2.2

42.9

1913

15926

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.0

42.3

584

3332

P01BA02

ATC

hydroxychloroquine; oral

2.8

42.1

232

892

L23.3

ICD-10 Finland

Allergic contact dermatitis due to drugs in contact with skin

54.4

40.6

L04AD01

ATC

ciclosporin; systemic

5.8

40.1

131

D11AH01

ATC

tacrolimus; topical

106.9

38.8

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

2.0

37.4

507

2859

N02AA05

ATC

oxycodone; systemic

2.1

37.3

406

2113

J45.9

ICD-10 Finland

Asthma, unspecified

2.0

37.1

453

2460

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.0

36.8

473

2616

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.5

36.6

243

1024

J01DA01

ATC

[U] cefalexin

1.8

36.6

1410

10878

N03AX16

ATC

[U] pregabalin

1.9

36.5

532

3073

J01MA14

ATC

moxifloxacin; systemic

2.6

36.0

229

945

TPH04

NOMESCO Finland

Cathetrisation of vein

2.0

36.0

514

2946

D07XC01

ATC

betamethasone; topical

2.4

35.8

268

1193

L04AA06

ATC

mycophenolic acid; systemic

5.5

35.8

131

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

3.4

35.7

134

413

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.9

35.6

107

284

C03CA01

ATC

furosemide; systemic

1.9

35.5

640

3955

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

4.1

35.5

100

253

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

3.3

35.5

141

450

JN4AD

NOMESCO Finland

Body CT examination

2.5

35.4

243

1039

Z01.8

ICD-10 Finland

Other specified special examinations

1.9

35.3

535

3127

R03BA02

ATC

budesonide; inhalant

2.0

35.2

439

2397

XQ848

NOMESCO Finland

Dermatological photography

4.8

35.2

175

N03AG01

ATC

valproic acid; systemic, rectal

2.9

35.1

176

642

L30.8

ICD-10 Finland

Other specified dermatitis

5.8

35.1

112

ZX120

NOMESCO Finland

Intravenous

2.4

34.7

250

1094

D02AE01

ATC

carbamide; topical

3.0

33.7

154

534

D07CC01

ATC

betamethasone and antibiotics; topical

2.3

33.6

284

1332

D07BC01

ATC

betamethasone and antiseptics; topical

2.4

33.5

255

1142

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

10.7

33.1

L40.0

ICD-10 Finland

Psoriasis vulgaris

3.6

32.9

111

319

L50.8

ICD-10 Finland

Other urticaria

5.2

32.8

134

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

6.8

32.3

J01FA06

ATC

roxithromycin; oral

1.7

32.1

891

6204

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.7

31.8

186

735

L21.8

ICD-10 Finland

Other seborrhoeic dermatitis

11.5

31.8

6930A

ICD-9 Finland

Dermatitis due to substances taken internally, Due to drugs and medicines[ECZEMA EX USU PHARMACIS]

+∞

31.3

R03AC02

ATC

salbutamol; inhalant

1.7

31.3

1249

9550

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

4.4

31.2

180

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

3.0

31.1

145

508

R03DC03

ATC

montelukast; oral

2.0

30.4

396

2186

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

4.2

30.4

205

A03FA01

ATC

metoclopramide; systemic, rectal

1.8

29.9

516

3122

D09AB01

ATC

zinc bandage without supplements; topical

6.8

29.3

A04AA01

ATC

ondansetron; systemic, rectal

2.4

29.3

206

889

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.7

29.3

170

669

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.8

29.0

578

3648

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.5

28.9

192

807

J01AA02

ATC

doxycycline; systemic

1.7

28.8

1680

14029

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.7

28.6

912

6533

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.0

28.3

360

1968

L30.0

ICD-10 Finland

Nummular dermatitis

4.2

28.2

186

R01AD08

ATC

fluticasone; nasal

1.7

28.1

648

4257

A92

ICPC

Allergy/allergic reaction NOS

3.5

27.9

100

299

L23.0

ICD-10 Finland

Allergic contact dermatitis due to metals

284.9

27.8

S01GX01

ATC

cromoglicic acid; ophthalmic

1.8

27.7

463

2767

D05BB02

ATC

acitretin; oral

4.7

27.6

139

R06.0

ICD-10 Finland

Dyspnoea

1.7

27.5

581

3722

J02AC01

ATC

fluconazole; systemic

1.6

27.5

882

6313

S88

ICPC

Dermatitis contact/allergic

4.5

27.4

152

J05AB01

ATC

aciclovir; systemic

1.8

27.2

498

3058

L26

ICD-10 Finland

Exfoliative dermatitis

+∞

27.1

D11AH02

ATC

pimecrolimus; topical

+∞

27.1

UJF32

NOMESCO Finland

Coloscopy

1.8

27.1

547

3456

H02AB02

ATC

dexamethasone; systemic

2.1

27.0

274

1379

JN4BD

NOMESCO Finland

Extensive body CT

2.2

26.6

236

1126

J05AB11

ATC

valaciclovir; oral

2.0

26.5

329

1781

N03AX12

ATC

[U] gabapentin; oral

1.9

26.5

362

2025

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.8

26.4

487

2995

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

26.3

824

5847

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.5

26.2

172

719

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

26.1

440

2631

M04AA01

ATC

allopurinol; systemic

2.1

26.1

274

1396

R01AD09

ATC

mometasone; nasal

1.6

26.0

1006

7509

R06AX13

ATC

loratadine; oral

1.9

25.8

352

1967

P01AB01

ATC

metronidazole; oral, rectal

1.6

25.7

873

6310

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.9

25.5

363

2058

J01XX08

ATC

linezolid; systemic

8.8

25.4

XG410

NOMESCO Finland

Flow-volume spirometry

3.1

25.3

107

354

R06AX22

ATC

ebastine; oral

1.9

25.3

378

2176

D11AX14

ATC

[U] tacrolimus

+∞

25.0

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

2.6

25.0

155

630

WZC30

NOMESCO Finland

Teaching

1.9

24.7

341

1912

R03AC03

ATC

terbutaline; inhalant

2.0

24.7

318

1742

J01FA09

ATC

clarithromycin; systemic

1.6

24.5

691

4756

JN3AD

NOMESCO Finland

Abdominal CT examination

2.1

24.4

248

1247

L01BA01

ATC

methotrexate; systemic

3.1

24.3

104

347

L20.8

ICD-10 Finland

Other atopic dermatitis

+∞

24.0

69100

ICD-8 Finland

Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum

+∞

24.0

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.0

23.7

294

1588

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.2

23.6

220

1068

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

5.1

23.3

N03AF01

ATC

carbamazepine; oral, rectal

2.7

23.3

129

496

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.0

22.9

294

1605

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

3.3

22.8

276

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.1

22.7

220

1084

J01FA10

ATC

azithromycin; systemic

1.5

22.4

1300

10501

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.2

22.4

213

1042

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.8

22.3

423

2611

X59

ICD-10 Finland

Exposure to unspecified factor

1.8

22.2

421

2596

R03BA05

ATC

fluticasone; inhalant

1.8

22.1

413

2536

N02BE01

ATC

paracetamol; systemic, rectal

1.8

22.1

1968

17582

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

7.1

22.1

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.1

22.1

238

1222

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

4.2

22.0

144

H02AB09

ATC

hydrocortisone; systemic

3.5

22.0

222

H04.10

ICD-10 Finland

Dry eye syndrome

2.0

22.0

250

1308

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

21.9

310

1747

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.5

21.9

147

620

R60.0

ICD-10 Finland

Localized oedema

2.0

21.9

256

1353

N03AF02

ATC

oxcarbazepine; oral

3.1

21.8

315

A02BC05

ATC

esomeprazole; systemic

1.6

21.8

845

6239

M79.6

ICD-10 Finland

Pain in limb

1.6

21.7

882

6578

N05CF01

ATC

zopiclone; oral

1.6

21.7

669

4683

N03AX09

ATC

lamotrigine; oral

2.6

21.7

130

520

WZC00

NOMESCO Finland

Treatment plan or consultation

1.6

21.5

801

5853

L04AA01

ATC

[U] ciclosporin

5.2

21.5

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.1

21.5

218

1094

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

21.3

924

6980

S29

ICPC

Skin symptom/complaint other

1.8

21.2

402

2476

V700A

ICD-9 Finland

General medical examination, Routine general medical examination at a health care facility

3.8

21.2

175

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

4.0

21.2

157

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.3

21.1

167

758

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.1

21.1

212

1060

A07EC01

ATC

sulfasalazine; oral, rectal

2.2

20.9

189

907

NF1AA

NOMESCO Finland

Hip X-ray examination

2.1

20.9

198

968

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.9

20.9

288

1610

XW000

NOMESCO Finland

Bone marrow biopsy

2.8

20.7

106

391

L23.8

ICD-10 Finland

Allergic contact dermatitis due to other agents

77.5

20.7

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

4.0

20.6

147

J01DA09

ATC

[U] cefadroxil

1.6

20.6

569

3870

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.2

20.6

182

865

AA1AD

NOMESCO Finland

CT of head and brain

1.6

20.6

550

3710

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.5

20.5

203

J46

ICD-10 Finland

Status asthmaticus

3.4

20.4

228

J01FA01

ATC

erythromycin; systemic

1.8

20.4

322

1877

A03

ICPC

Fever

1.7

20.4

411

2573

XG474

NOMESCO Finland

Exhalation nntrogen oxide

3.4

20.3

219

N03AX14

ATC

levetiracetam; systemic

3.3

20.3

244

L23.2

ICD-10 Finland

Allergic contact dermatitis due to cosmetics

48.5

20.2

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

3.5

20.1

201

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

3.2

20.0

262

WW500

NOMESCO Finland

Blood transfusion

2.8

19.9

104

388

L27.8

ICD-10 Finland

Dermatitis due to other substances taken internally

+∞

19.8

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

19.8

659

4679

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

19.7

1102

8738

TPX10

NOMESCO Finland

Implantation of vascular injection port

3.2

19.7

259

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

19.5

881

6679

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.4

19.4

132

561

S18

ICPC

Laceration/cut

1.5

19.2

930

7149

N05BA04

ATC

oxazepam; oral

1.6

19.0

563

3884

SPAT1263

SPAT

Sampling

1.5

18.9

915

7026

E000007, ,

ATC

2.7

18.8

106

411

M54.5

ICD-10 Finland

Low back pain

1.5

18.7

755

5578

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.0

18.7

224

1193

A02BC03

ATC

lansoprazole; oral

1.6

18.4

584

4091

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

18.3

524

3579

R02

ICPC

Shortness of breath/dyspnoea

1.8

18.2

274

1572

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

18.0

907

7001

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.4

18.0

129

561

B01AB05

ATC

enoxaparin; parenteral

1.5

18.0

634

4542

A07AA02

ATC

nystatin; oral

2.4

17.9

130

569

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.0

17.8

200

1040

S97

ICPC

Chronic ulcer skin

2.4

17.5

127

555

L51.9

ICD-10 Finland

Erythema multiforme, unspecified

15.7

17.5

TGC00

NOMESCO Finland

Bronchial lavation

3.4

17.4

185

S76

ICPC

Skin infection other

2.4

17.4

119

507

D70.82

ICD-10 Finland

Drug-induced neutropenia

4.1

17.3

116

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.9

17.3

134

Z51.5

ICD-10 Finland

Palliative care

2.1

17.2

160

775

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.7

17.1

366

GD1AD

NOMESCO Finland

Thorax CT examination

2.4

17.0

120

518

N06AX21

ATC

duloxetine; oral

1.8

17.0

253

1445

K52.2

ICD-10 Finland

Allergic and dietetic gastroenteritis and colitis

7.6

17.0

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

4.6

16.8

127

Kela drug reimbursment

Transplant complication

4.2

16.7

106

L23.5

ICD-10 Finland

Allergic contact dermatitis due to other chemical products

35.3

16.7

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

4.2

16.5

107

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

2.7

16.5

338

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.4

16.4

120

526

R51.80

ICD-10 Finland

Headache

1.7

16.4

349

2208

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

16.3

533

3741

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

2.5

16.2

104

430

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.7

16.2

368

2369

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.8

16.1

270

1599

SPAT1260

SPAT

Consultation of another employee

1.7

16.0

362

2326

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.5

15.9

100

409

A04AA02

ATC

granisetron; systemic, transdermal

2.2

15.9

141

671

J45.1

ICD-10 Finland

Nonallergic asthma

2.1

15.9

161

807

J45

ICD-10 Finland

Asthma

1.9

15.8

214

1185

M13.9

ICD-10 Finland

Arthritis, unspecified

2.1

15.8

161

808

N05BA01

ATC

diazepam; systemic, rectal

1.8

15.8

275

1646

X57

ICD-10 Finland

Unspecified privation

3.3

15.8

182

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.1

15.8

149

727

SPAT1153

SPAT

Removal of sutures

1.5

15.7

623

4554

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.0

15.7

185

978

R60.9

ICD-10 Finland

Oedema, unspecified

2.3

15.7

115

505

ZXD05

NOMESCO Finland

Urgent procedure

1.5

15.6

634

4658

L04AA13

ATC

[U] leflunomide

3.1

15.6

209

S87

ICPC

Dermatitis/atopic eczema

3.7

15.5

135

L51.0

ICD-10 Finland

Nonbullous erythema multiforme

22.2

15.5

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.7

15.5

284

1724

R53

ICD-10 Finland

Malaise and fatigue

1.5

15.5

505

3539

SPAT1255

SPAT

Intravenous administration of medicine

2.1

15.5

146

712

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.9

15.4

259

R01AD12

ATC

fluticasone furoate; nasal

1.5

15.3

660

4902

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.2

15.3

129

601

L17

ICPC

Foot/toe symptom/complaint

1.5

15.3

590

4284

C07AB07

ATC

bisoprolol; oral

1.4

15.2

920

7287

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.7

15.2

325

2058

L04AB04

ATC

adalimumab; parenteral

3.1

15.2

202

SPAT1301

SPAT

No procedures

1.5

15.1

648

4806

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

4.3

15.0

ZYC01

NOMESCO Finland

Remote contact by phone

2.2

15.0

136

653

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.2

14.9

134

641

L29.9

ICD-10 Finland

Pruritus, unspecified

3.5

14.9

144

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.7

14.8

130

E930A

ICD-9 Finland

Antibiotics[PENISILLIINIT]

31.9

14.8

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

3.3

14.8

174

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.9

14.8

232

SPAT1229

SPAT

Assessment of need for aid

2.0

14.5

157

806

L03AA02

ATC

filgrastim; parenteral

2.8

14.4

263

L40.5

ICD-10 Finland

Arthropathic psoriasis

3.7

14.3

124

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

14.2

611

4528

WX002

NOMESCO Finland

Sedation and analgesia

1.6

14.1

381

2552

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.7

14.1

287

1791

N03AX18

ATC

lacosamide; systemic

5.1

14.1

WW200

NOMESCO Finland

Immunization

2.9

14.1

238

M25.5

ICD-10 Finland

Pain in joint

1.5

14.1

645

4834

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

14.1

546

3961

T88.6

ICD-10 Finland

Anaphylactic shock due to adverse effect of correct drug or medicament properly administered

14.5

14.0

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.4

14.0

145

ZX112

NOMESCO Finland

Subcutaneous

3.1

13.9

181

D07XB05

ATC

dexamethasone; topical

3.1

13.9

181

E000004, ,

ATC

3.8

13.9

108

UKC02

NOMESCO Finland

Cystoscopy

1.7

13.9

284

1775

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.9

13.9

183

1005

A02BC01

ATC

omeprazole; systemic

1.5

13.8

544

3955

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

3.1

13.8

187

L23.9

ICD-10 Finland

Allergic contact dermatitis, unspecified cause

11.5

13.8

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

13.7

318

2051

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.2

13.7

113

522

SPAT1254

SPAT

Administration of medicine

1.6

13.6

325

2114

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

5.5

13.5

A41.9

ICD-10 Finland

Sepsis, unspecified

2.6

13.4

314

L28.0

ICD-10 Finland

Lichen simplex chronicus

18.3

13.4

R42

ICD-10 Finland

Dizziness and giddiness

1.5

13.3

444

3115

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

3.4

13.3

140

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

13.3

823

6505

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.4

13.2

655

4976

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

13.1

1100

9145

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.3

13.1

435

D07AC14

ATC

methylprednisolone aceponate; topical

2.4

13.0

373

M79.1

ICD-10 Finland

Myalgia

1.6

12.9

305

1975

T78.3

ICD-10 Finland

Angioneurotic oedema

4.0

12.9

J20

ICD-10 Finland

Acute bronchitis

1.8

12.9

209

1223

A02BA02

ATC

ranitidine; systemic

1.6

12.9

367

2486

J01EA01

ATC

trimethoprim; systemic

1.5

12.8

542

3989

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.2

12.8

110

517

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

12.8

140

722

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.1

12.7

124

612

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.3

12.7

144

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.9

12.7

171

945

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.5

12.7

317

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

12.6

250

1547

S06

ICPC

Rash localized

2.1

12.6

119

580

D64.9

ICD-10 Finland

Anaemia, unspecified

1.8

12.6

198

1148

D05AX52

ATC

calcipotriol, combinations; topical

2.3

12.6

436

D11AX15

ATC

[U] pimecrolimus

+∞

12.5

L24.0

ICD-10 Finland

Irritant contact dermatitis due to detergents

+∞

12.5

S21

ICPC

Skin texture symptom/complaint

1.7

12.5

271

1718

D07AB01

ATC

clobetasone; topical

2.7

12.4

249

Z88.1

ICD-10 Finland

Personal history of allergy to other antibiotic agents

130.7

12.4

R01BA52

ATC

pseudoephedrine, combinations; oral

1.5

12.4

564

4204

A07EA06

ATC

budesonide; oral, local oral

2.5

12.4

332

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.8

12.4

179

1011

SPAT1325

SPAT

Vaccination

1.4

12.4

676

5212

XX3DW

NOMESCO Finland

Time consuming IT work

1.7

12.3

213

1270

N05BA09

ATC

clobazam; oral

5.4

12.3

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

5.4

12.3

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.4

12.2

372

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

2.5

12.2

305

153

Kela drug reimbursment

Lenalidomid

5.5

12.1

L04AX04

ATC

lenalidomide; oral

5.5

12.1

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

12.5

12.1

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

3.2

12.1

149

A10AB05

ATC

insulin aspart; parenteral

1.9

12.1

156

851

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

4.1

12.0

L71.9

ICD-10 Finland

Rosacea, unspecified

2.9

12.0

197

N30.0

ICD-10 Finland

Acute cystitis

1.6

12.0

337

2273

UDC00

NOMESCO Finland

Ear microscopy

1.9

12.0

157

860

R01AD58

ATC

fluticasone, combinations; nasal

1.5

12.0

491

3587

N06AX11

ATC

mirtazapine; oral

1.4

11.9

668

5170

M03BX02

ATC

tizanidine; oral

1.4

11.9

1239

10600

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.4

11.9

364

L50.1

ICD-10 Finland

Idiopathic urticaria

5.4

11.8

TK800

NOMESCO Finland

Hemodialysis

3.3

11.8

136

ZXE00

NOMESCO Finland

One hour or less

1.4

11.7

797

6367

E66.01

ICD-10 Finland

Obesity due to excess calories

1.8

11.7

187

1090

A11CC03

ATC

alfacalcidol; systemic

2.9

11.7

184

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.4

11.7

336

R03AC12

ATC

salmeterol; inhalant

2.3

11.6

406

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

3.1

11.6

153

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.7

11.6

235

1464

L40.9

ICD-10 Finland

Psoriasis, unspecified

3.8

11.6

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.0

11.5

126

649

6929X

ICD-9 Finland

Contact dermatitis and other eczema, Unspecified cause[DERMATITITIS ARTEFACTA NUD]

+∞

11.5

134

Kela drug reimbursment

General erythroderma

13.7

11.4

D01AC02

ATC

miconazole; topical

1.9

11.4

143

772

J45.8

ICD-10 Finland

Mixed asthma

2.6

11.4

255

212

Kela drug reimbursment

Gout

3.3

11.4

129

L04AB01

ATC

etanercept; parenteral

3.3

11.4

129

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

2.5

11.3

285

N02BF02

ATC

pregabalin; oral

2.0

11.3

115

577

L50

ICD-10 Finland

Urticaria

3.1

11.3

155

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.7

11.3

227

R11

ICD-10 Finland

Nausea and vomiting

1.7

11.3

191

1132

Z94.0

ICD-10 Finland

Kidney transplant status

4.2

11.3

N06AX16

ATC

venlafaxine; oral

1.6

11.3

286

1883

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.8

11.3

210

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.2

11.3

140

L40.8

ICD-10 Finland

Other psoriasis

5.6

11.2

N18.8

ICD-10 Finland

Other chronic renal failure

3.0

11.2

167

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.2

11.2

400

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

11.1

292

1937

L28

ICPC

Limited function/disability (L)

1.5

11.1

324

2201

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

11.1

559

4235

A10AC01

ATC

insulin (human); parenteral

1.8

11.1

155

868

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.7

11.1

235

1481

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

3.0

11.1

168

J01FA15

ATC

telithromycin; oral

1.7

11.0

193

1155

NH3EA

NOMESCO Finland

Feet X-ray examination with load

3.1

11.0

142

L03AA13

ATC

pegfilgrastim; parenteral

2.2

11.0

442

S02

ICPC

Pruritus

2.4

11.0

302

J01CE08

ATC

benzathine benzylpenicillin; parenteral

4.8

11.0

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.6

10.8

268

1754

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

2.1

10.8

108

539

D69.0

ICD-10 Finland

Allergic purpura

5.2

10.8

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

4.0

10.8

L93.0

ICD-10 Finland

Discoid lupus erythematosus

8.9

10.8

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.8

10.7

155

876

G47.3

ICD-10 Finland

Sleep apnoea

1.5

10.7

389

2767

SPAT1312

SPAT

General health counselling

1.4

10.7

660

5170

D06AX01

ATC

fusidic acid; topical

1.7

10.7

191

1148

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.3

10.7

330

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

3.5

10.7

104

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

3.5

10.7

104

B35.3

ICD-10 Finland

Tinea pedis

2.3

10.7

375

C08CA01

ATC

amlodipine; oral

1.4

10.7

677

5330

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.4

10.6

294

L30

ICD-10 Finland

Other dermatitis

3.0

10.6

161

XCK00

NOMESCO Finland

Perimetry

2.0

10.6

116

599

D05AX03

ATC

calcitriol; topical

3.9

10.6

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

10.6

350

2444

R96

ICPC

Asthma

1.7

10.5

186

1115

UJF30

NOMESCO Finland

Ileoscopy through colon

1.7

10.5

193

1170

R03AK08

ATC

formoterol and beclometasone; inhalant

2.2

10.5

417

Z49.1

ICD-10 Finland

Extracorporeal dialysis

4.0

10.5

L04AD02

ATC

tacrolimus; systemic

4.0

10.5

137

Kela drug reimbursment

Uraemia requiring dialysis

4.8

10.5

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.8

10.5

147

824

TPH07

NOMESCO Finland

Cathetrisation of artery

1.7

10.5

203

1249

Z3231

NOMESCO Finland

Registered nurse

1.4

10.5

531

4023

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.8

10.4

169

989

A03FA02

ATC

cisapride; oral, rectal

1.8

10.4

147

825

L50.3

ICD-10 Finland

Dermatographic urticaria

3.3

10.4

116

B07.9

ICD-10 Finland

Verruca simplex

2.3

10.4

341

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.8

10.4

172

1013

L21.9

ICD-10 Finland

Seborrhoeic dermatitis, unspecified

3.6

10.4

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.1

10.4

466

D11AH05

ATC

dupilumab; topical

32.7

10.3

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.7

10.3

202

1246

L88

ICPC

Rheumatoid/seropositive arthritis

2.2

10.3

381

R03BA01

ATC

beclometasone; inhalant

1.6

10.3

265

1751

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

10.3

469

3486

K07

ICPC

Swollen ankles/oedema

2.2

10.3

421

C91.4

ICD-10 Finland

Hairy-cell leukaemia

23.5

10.2

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.7

10.2

178

1063

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

3.8

10.2

R03AC13

ATC

formoterol; inhalant

2.1

10.2

489

I50.9

ICD-10 Finland

Heart failure, unspecified

1.6

10.2

234

1503

R07.3

ICD-10 Finland

Other chest pain

1.7

10.2

196

1204

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.8

10.1

141

788

A01AB09

ATC

miconazole; local oral

1.7

10.1

173

1028

B01AB10

ATC

tinzaparin; parenteral

1.7

10.1

191

1167

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

2.9

10.1

166

M01AH05

ATC

etoricoxib; oral

1.3

10.1

1202

10383

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

5.0

10.0

L16

ICPC

Ankle symptom/complaint

1.6

10.0

236

1525

M01AE02

ATC

naproxen; oral, rectal

1.3

10.0

1182

10191

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

4.8

10.0

ZXX04

NOMESCO Finland

Extent of procedure, 4 units

10.1

10.0

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.2

10.0

373

WXQ12

NOMESCO Finland

Psoralen - Ultraviolet A therapy with local sensitivisation

40.2

10.0

X58

ICD-10 Finland

Exposure to other specified factors

1.5

10.0

282

1903

B02.9

ICD-10 Finland

Zoster without complication

1.9

9.9

123

662

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

9.9

1508

13474

H60.1

ICD-10 Finland

Cellulitis of external ear

3.9

9.9

J32.4

ICD-10 Finland

Chronic pansinusitis

3.3

9.9

110

Z71.8

ICD-10 Finland

Other specified counselling

1.4

9.8

621

4874

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

9.8

595

4639

B03XA02

ATC

darbepoetin alfa; parenteral

2.9

9.8

163

L51.1

ICD-10 Finland

Bullous erythema multiforme

20.1

9.8

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.7

9.8

179

1084

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

4.7

9.8

J30.3

ICD-10 Finland

Other allergic rhinitis

2.3

9.7

338

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

3.2

9.7

116

M05BX04

ATC

denosumab; parenteral

1.9

9.7

114

603

M70.6

ICD-10 Finland

Trochanteric bursitis

1.6

9.7

244

1602

WX892

NOMESCO Finland

Monitored bed care

1.8

9.7

142

807

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.5

9.6

246

S06.0

ICD-10 Finland

Concussion

1.6

9.6

215

1372

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.6

9.6

226

1460

M07.3

ICD-10 Finland

Other psoriatic arthropathies

3.9

9.6

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.9

9.6

112

592

A04

ICPC

Weakness/tiredness general

1.5

9.6

303

2094

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.5

9.5

235

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

4.5

9.5

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.8

9.5

130

723

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.8

9.5

129

716

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.8

9.5

146

842

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

9.5

685

5486

K30

ICD-10 Finland

Functional dyspepsia

1.6

9.5

212

1353

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.4

9.5

285

E930W

ICD-9 Finland

Antibiotics[MUUT MÄÄRITELLYT ANTIBIOOTIT]

100.4

9.4

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

9.4

799

6553

M32.0

ICD-10 Finland

Drug-induced systemic lupus erythematosus

30.1

9.4

7100A

ICD-9 Finland

Diffuse diseases of connective tissue, Systemic lupus erythematosus

17.6

9.4

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.5

9.4

231

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

9.4

241

1591

L01BB02

ATC

mercaptopurine; oral

3.4

9.3

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.9

9.3

108

569

H66.9

ICD-10 Finland

Otitis media, unspecified

1.8

9.3

147

854

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.8

9.3

142

817

QDE99

NOMESCO Finland

Other excision or repair of lesion of skin of lower limb

4.7

9.3

183

Kela drug reimbursment

Lamotrigin and topiramate

4.1

9.2

K59.1

ICD-10 Finland

Functional diarrhoea

1.9

9.2

111

593

A07AA09

ATC

vancomycin; oral

3.5

9.2

H03AA01

ATC

levothyroxine sodium; systemic

1.4

9.2

450

3380

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

7.7

9.1

C08CA13

ATC

lercanidipine; oral

1.6

9.1

245

1633

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.9

9.1

117

638

R74

ICPC

Upper respiratory infection acute

1.3

9.1

665

5328

UDM02

NOMESCO Finland

Sinoscopy

2.7

9.1

176

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

3.5

9.1

EMB10

NOMESCO Finland

Tonsillectomy

1.8

9.1

124

690

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

9.0

331

2355

A12AA04

ATC

calcium carbonate; oral

3.4

9.0

R06.2

ICD-10 Finland

Wheezing

2.0

9.0

457

N06AA09

ATC

amitriptyline; systemic

1.7

9.0

171

1047

N18.0

ICD-10 Finland

End-stage renal disease

4.1

9.0

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.7

9.0

149

879

S01

ICPC

Pain/tenderness of skin

2.0

9.0

451

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.1

9.0

417

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

8.9

244

1632

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.7

8.9

156

933

T78.0

ICD-10 Finland

Anaphylactic shock due to adverse food reaction

18.7

8.9

D05AX02

ATC

calcipotriol; topical

2.3

8.9

293

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

2.0

8.9

452

9940/3-C42.1

ICD-O-3

Hairy cell leukemia, NOS, of bone marrow

24.1

8.9

L40.1

ICD-10 Finland

Generalized pustular psoriasis

24.1

8.9

M32.1

ICD-10 Finland

Systemic lupus erythematosus with organ or system involvement

24.1

8.9

Z51.6

ICD-10 Finland

Desensitization to allergens

3.4

8.9

ZXH09, ,

SPAT

2.5

8.9

207

WZA10

NOMESCO Finland

Extensive medical or dental certificate

3.3

8.9

102

L01

ICPC

Neck symptom/complaint

1.5

8.9

307

2159

N03AE01

ATC

clonazepam; systemic

1.9

8.9

106

565

N02BF01

ATC

gabapentin; oral

1.7

8.9

152

905

Z01.2

ICD-10 Finland

Dental examination

1.3

8.8

928

7824

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.5

8.8

321

2281

L29.8

ICD-10 Finland

Other pruritus

4.0

8.8

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

4.0

8.8

A06AD11

ATC

lactulose; oral

1.5

8.8

268

1837

XF400

NOMESCO Finland

ECG with 12 standard connections

1.5

8.8

289

2013

L04AC07

ATC

tocilizumab; parenteral

9.5

8.8

M05BA04

ATC

alendronic acid; oral

1.7

8.8

160

969

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.5

8.7

221

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.8

8.7

130

743

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.4

8.7

398

2951

M01AH02

ATC

rofecoxib; oral

1.6

8.7

226

1495

A28

ICPC

Limited function/disability NOS

1.5

8.7

294

2059

ZXA10

NOMESCO Finland

Bilateral

1.4

8.7

348

2519

XQ832

NOMESCO Finland

Other provocation test

50.2

8.7

L23.1

ICD-10 Finland

Allergic contact dermatitis due to adhesives

50.2

8.7

H01

ICPC

Ear pain/earache

1.6

8.7

232

1545

ZY010

NOMESCO Finland

Hospital outpatient

1.9

8.7

110

598

L04AB06

ATC

golimumab; parenteral

4.3

8.7

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

8.6

386

2851

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

4.0

8.6

L13

ICPC

Hip symptom/complaint

1.5

8.6

331

2378

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.8

8.6

120

673

ZYC06

NOMESCO Finland

Real-time text-based remote transaction

10.1

8.5

R55

ICD-10 Finland

Syncope and collapse

1.6

8.5

196

1260

J01XC01

ATC

fusidic acid; systemic

3.4

8.5

395

Kela drug reimbursment

Dupilumab

27.6

8.5

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

8.5

405

3027

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.0

8.4

427

SPAT1310

SPAT

Counselling related to known health issue

1.3

8.4

623

4992

WIX00

NOMESCO Finland

Allergy cleanup guidance

90.4

8.4

XQ830

NOMESCO Finland

Exposure to foodstuff

90.4

8.4

Z2446

NOMESCO Finland

Social worker

1.7

8.4

137

804

K50.1

ICD-10 Finland

Crohn disease of large intestine

3.6

8.4

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

8.4

295

2083

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.0

8.4

484

6929B

ICD-9 Finland

Contact dermatitis and other eczema, Unspecified cause[ECZEMA INFECTIOSUM]

+∞

8.3

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

8.3

341

2477

N06AB04

ATC

citalopram; systemic

1.4

8.3

379

2807

S01AD03

ATC

aciclovir; ophthalmic

2.2

8.3

302

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

2.8

8.3

150

JN6AD

NOMESCO Finland

CT of torso and neck

3.1

8.3

107

C10AC01

ATC

colestyramine; oral

2.5

8.2

209

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

2.8

8.2

145

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

2.7

8.2

162

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.9

8.2

522

J02AC02

ATC

itraconazole; systemic

1.5

8.2

306

2183

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

3.4

8.2

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

3.3

8.2

K02.1

ICD-10 Finland

Caries of dentine

1.3

8.2

1217

10702

R01AD01

ATC

beclometasone; nasal

1.5

8.2

281

1972

R01AC01

ATC

cromoglicic acid; nasal

2.1

8.2

370

M35.3

ICD-10 Finland

Polymyalgia rheumatica

2.1

8.2

370

C07AA05

ATC

propranolol; systemic

1.4

8.2

400

2998

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

4.2

8.2

Z00.0

ICD-10 Finland

General medical examination

1.4

8.1

372

2756

D06BX01

ATC

metronidazole; topical

1.6

8.1

190

1226

V03AE01

ATC

polystyrene sulfonate; oral

3.6

8.1

Y88

ICD-10 Finland

Sequelae with surgical and medical care as external cause

4.8

8.1

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

2.3

8.1

248

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.3

8.1

267

K12.00

ICD-10 Finland

Recurrent oral aphthae

3.0

8.1

119

N06AB10

ATC

escitalopram; oral

1.4

8.1

405

3049

E931A

ICD-9 Finland

Other anti-infectives[SULFONAMIDIT]

33.5

8.1

N03AB02

ATC

phenytoin; systemic

3.4

8.1

6960A

ICD-9 Finland

Psoriasis and similar disorders, Psoriatic arthropathy

11.7

8.1

XQ845

NOMESCO Finland

Dermatoscopy

3.0

8.0

114

130

Kela drug reimbursment

Malignant tumour

1.7

8.0

148

899

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

8.0

362

2676

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

8.0

1071

9284

H25.8

ICD-10 Finland

Other senile cataract

1.6

8.0

181

1159

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.4

8.0

237

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

3.1

8.0

104

J01CA04

ATC

amoxicillin; systemic

1.3

8.0

1776

16454

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

3.5

8.0

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

2.4

8.0

231

L04AC05

ATC

ustekinumab; parenteral

7.2

8.0

A07EC02

ATC

mesalazine; oral, rectal

1.9

7.9

101

550

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.7

7.9

134

795

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

4.4

7.9

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.5

7.9

277

1953

R05

ICD-10 Finland

Cough

1.4

7.9

399

3008

J01DC02

ATC

cefuroxime; systemic

1.8

7.9

107

595

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.2

7.9

296

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.8

7.9

132

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.6

7.8

196

1285

L53.9

ICD-10 Finland

Erythematous condition, unspecified

3.5

7.8

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

3.0

7.8

116

J04AB02

ATC

rifampicin; systemic

3.3

7.8

B01AC04

ATC

clopidogrel; oral

1.5

7.8

263

1841

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

7.8

272

R31

ICD-10 Finland

Unspecified haematuria

1.6

7.7

169

1073

ZXE20

NOMESCO Finland

More than three and less than five hours

1.5

7.7

240

1651

W19

ICD-10 Finland

Unspecified fall

1.6

7.7

179

1154

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.4

7.7

204

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

2.7

7.7

145

WQ000

NOMESCO Finland

Hyposensibilisation

4.5

7.6

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.0

7.6

415

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

2.4

7.6

211

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.3

7.6

236

H10.1

ICD-10 Finland

Acute atopic conjunctivitis

2.4

7.6

205

R01AD11

ATC

triamcinolone; nasal

1.6

7.6

158

991

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

7.6

308

2233

S70

ICPC

Herpes zoster

2.4

7.5

212

G43.9

ICD-10 Finland

Migraine, unspecified

1.7

7.5

125

738

S91

ICPC

Psoriasis

4.1

7.5

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

7.5

410

L21.0

ICD-10 Finland

Seborrhoea capitis

6.2

7.5

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.9

7.5

495

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

2.5

7.5

176

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.9

7.5

481

SPAT1262

SPAT

Handing over of treatment supplies

1.4

7.5

303

2194

W10

ICD-10 Finland

Fall on and from stairs and steps

1.9

7.5

539

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.5

7.5

237

1637

S28

ICPC

Limited function/disability (S)

4.2

7.5

J33.8

ICD-10 Finland

Other polyp of sinus

2.6

7.5

153

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.1

7.4

303

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.0

7.4

398

K50.9

ICD-10 Finland

Crohn disease, unspecified

2.9

7.4

114

R03BA08

ATC

ciclesonide; inhalant

1.6

7.4

154

965

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

3.9

7.4

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.6

7.4

182

1188

ZXA05

NOMESCO Finland

Left side

1.4

7.4

440

3402

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

3.2

7.4

J01DA06

ATC

[U] cefuroxime

1.5

7.4

263

1860

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.7

7.3

132

797

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.1

7.3

325

K50.8

ICD-10 Finland

Other Crohn disease

2.8

7.3

126

L03

ICPC

Low back symptom/complaint

1.3

7.3

530

4221

H65.3

ICD-10 Finland

Chronic mucoid otitis media

2.2

7.3

253

S11

ICPC

Skin infection post-traumatic

3.1

7.3

R06AX26

ATC

fexofenadine; oral

1.7

7.3

120

707

L27

ICD-10 Finland

Dermatitis due to substances taken internally

+∞

7.3

6938X

ICD-9 Finland

Dermatitis due to substances taken internally, Due to other specified substances taken internally

+∞

7.3

69299

ICD-8 Finland

Other eczema and dermatitis, Due to other and unspecified cause

+∞

7.3

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.8

7.3

132

SCA03

NOMESCO Finland

Preventive oral health care, extensive

1.8

7.3

101

566

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.7

7.3

130

784

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

2.5

7.3

179

A01AB04

ATC

amphotericin B; local oral

1.9

7.3

451

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.9

7.3

444

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.6

7.2

167

1075

318

Kela drug reimbursment

Teriparatide

6.2

7.2

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.1

7.2

307

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.1

7.2

294

R00.2

ICD-10 Finland

Palpitations

1.6

7.2

149

934

R52.9

ICD-10 Finland

Pain, unspecified

1.6

7.2

175

1141

49300

ICD-8 Finland

Asthma, bronchiale

2.5

7.2

168

B05DA

ATC

Isotonic solutions

4.5

7.2

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

7.2

438

3400

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

2.8

7.2

122

L01.0

ICD-10 Finland

Impetigo [any organism] [any site]

2.8

7.2

122

M01CB01

ATC

sodium aurothiomalate; parenteral

2.9

7.2

111

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.6

7.2

186

1231

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.9

7.1

425

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

7.1

602

4896

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

7.1

231

1602

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

3.6

7.1

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.8

7.1

106

607

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

7.1

798

6737

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

2.1

7.1

289

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

2.5

7.1

163

D11

ICPC

Diarrhoea

1.5

7.1

232

1613

UJK02

NOMESCO Finland

ERCP

2.3

7.1

212

A40.3

ICD-10 Finland

Sepsis due to Streptococcus pneumoniae

4.1

7.1

R21

ICPC

Throat symptom/complaint

1.4

7.1

439

3416

ZSN00

NOMESCO Finland

Procedure related to previous procedure classified in chapter N

6.0

7.1

7080A

ICD-9 Finland

Urticaria, Allergic urticaria

8.8

7.0

R4110

NOMESCO Finland

Physiotherapy

1.3

7.0

506

4025

N05AH04

ATC

quetiapine; oral

1.4

7.0

339

2534

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.6

7.0

172

1124

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

3.5

7.0

K65.0

ICD-10 Finland

Acute peritonitis

3.5

7.0

J47

ICD-10 Finland

Bronchiectasis

2.7

7.0

141

P03

ICPC

Feeling depressed

1.5

7.0

200

1353

N30.9

ICD-10 Finland

Cystitis, unspecified

1.7

6.9

118

702

128

Kela drug reimbursment

Cancers of female genital organs

2.5

6.9

159

K07.60

ICD-10 Finland

Snapping jaw

1.8

6.9

104

597

H05AA02

ATC

teriparatide; parenteral

6.3

6.9

S01GX02

ATC

levocabastine; ophthalmic

1.8

6.9

106

612

D06BB03

ATC

aciclovir; topical

1.9

6.9

437

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.6

6.9

139

865

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.2

6.9

240

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

6.9

521

4171

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

2.6

6.9

142

J01CF02

ATC

cloxacillin; systemic

2.5

6.8

166

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

2.8

6.8

114

C09CA06

ATC

candesartan; oral

1.4

6.8

417

3234

M13.1

ICD-10 Finland

Monoarthritis, not elsewhere classified

3.2

6.8

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

3.5

6.8

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.4

6.8

310

2291

PH2DE

NOMESCO Finland

Ultrasound examination of bloodflow in veins of lower extremity with Doppler method

2.3

6.8

222

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

4.1

6.8

J31.0

ICD-10 Finland

Chronic rhinitis

1.6

6.8

152

971

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.3

6.8

483

3835

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.1

6.8

275

L51.19

ICD-10 Finland

Other bullous erythema multiforme

40.2

6.8

R20.2

ICD-10 Finland

Paraesthesia of skin

1.7

6.8

123

746

I45.9

ICD-10 Finland

Conduction disorder, unspecified

3.5

6.7

J01DA08

ATC

[U] cefaclor

1.5

6.7

248

1766

QDB10, ,

SPAT

2.8

6.7

121

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

2.8

6.7

110

TAB00

NOMESCO Finland

Lumbar puncture

1.9

6.7

443

S80.0

ICD-10 Finland

Contusion of knee

1.6

6.6

142

898

V03AE02

ATC

sevelamer; oral

7.8

6.6

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.5

6.6

157

R75

ICPC

Sinusitis acute/chronic

1.8

6.6

554

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.9

6.6

423

B34.9

ICD-10 Finland

Viral infection, unspecified

2.1

6.6

305

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.7

6.6

124

760

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

4.2

6.5

M10

ICD-10 Finland

Gout

2.0

6.5

340

O99.1

ICD-10 Finland

Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium

3.8

6.5

J32.2

ICD-10 Finland

Chronic ethmoidal sinusitis

3.8

6.5

R5140

NOMESCO Finland

Monitoring the use of the aid

1.5

6.5

175

1167

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.8

6.5

564

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

2.7

6.5

129

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.7

6.5

112

670

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.3

6.5

429

3367

A01AC01

ATC

triamcinolone; local oral

2.8

6.5

112

H53.1

ICD-10 Finland

Subjective visual disturbances

1.7

6.5

115

693

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.1

6.5

300

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

3.7

6.5

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.3

6.5

202

SPAT1240

SPAT

Therapeutic discussion

1.5

6.4

210

1459

R06.4

ICD-10 Finland

Hyperventilation

2.7

6.4

118

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

2.5

6.4

153

1XC02, ,

NOMESCO Finland

3.9

6.4

L20

ICPC

Joint symptom/complaint NOS

2.0

6.4

342

Z3229

NOMESCO Finland

Other healthcare associate professional

1.6

6.4

147

945

WXQ10

NOMESCO Finland

Psoralen - Ultraviolet A therapy with systemic sensitivisation

70.0

6.4

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

1.8

6.4

514

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.7

6.4

109

649

N30.2

ICD-10 Finland

Other chronic cystitis

3.4

6.4

L08

ICPC

Shoulder symptom/complaint

1.4

6.4

384

2970

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.1

6.4

268

M79.7

ICD-10 Finland

Fibromyalgia

2.0

6.4

336

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

3.0

6.4

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

2.1

6.4

295

R03BB07

ATC

umeclidinium bromide; inhalant

3.7

6.4

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

2.1

6.4

262

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.3

6.3

191

Y89.9

ICD-10 Finland

Sequelae of unspecified external cause

3.0

6.3

S89.9

ICD-10 Finland

Unspecified injury of lower leg

2.0

6.3

337

K90.0

ICD-10 Finland

Coeliac disease

2.1

6.3

269

N05CD07

ATC

temazepam; oral

1.5

6.3

195

1340

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

1.8

6.3

466

J04BA02

ATC

dapsone; oral

5.5

6.3

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

18.1

6.3

T79.3

ICD-10 Finland

Post-traumatic wound infection, not elsewhere classified

2.8

6.3

103

E930F

ICD-9 Finland

Antibiotics[KEFALOSPORIINIT]

+∞

6.3

6918C

ICD-9 Finland

Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[DIATHESIS (CONSTITUTIO) ATOPICA]

+∞

6.3

69282

ICD-8 Finland

Other eczema and dermatitis, E microbis

+∞

6.3

L43.8

ICD-10 Finland

Other lichen planus

2.7

6.3

120

N08.5*M32.1

ICD-10 Finland

Glomerular disorders in systemic lupus erythematosus

26.7

6.2

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

6.2

1389

12632

WX882

NOMESCO Finland

High dependency care

2.1

6.2

271

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

2.6

6.2

138

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.6

6.2

138

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.5

6.2

150

G44.2

ICD-10 Finland

Tension-type headache

1.4

6.2

252

1828

I83.2

ICD-10 Finland

Varicose veins of lower extremities with both ulcer and inflammation

4.0

6.2

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

3.1

6.2

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

2.3

6.2

200

P25

ICPC

Phase of life problem adult

1.8

6.1

477

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

6.1

1483

13596

M02AA10

ATC

ketoprofen; topical

1.4

6.1

273

2010

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.5

6.1

179

1216

L14

ICPC

Leg/thigh symptom/complaint

1.6

6.1

142

916

SAA04

NOMESCO Finland

Special examination of mouth

1.7

6.1

111

673

H53.4

ICD-10 Finland

Visual field defects

2.5

6.1

151

R06AX11

ATC

astemizole; oral

2.1

6.1

273

XKD00

NOMESCO Finland

Uroflowmetry

1.5

6.1

221

1568

R68.2

ICD-10 Finland

Dry mouth, unspecified

4.1

6.1

JAH01

NOMESCO Finland

Laparoscopy

1.8

6.1

442

S01BA01

ATC

dexamethasone; ophthalmic

2.0

6.1

287

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.7

6.1

102

606

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.3

6.0

189

R01AD05

ATC

budesonide; nasal

1.6

6.0

133

848

L25.9

ICD-10 Finland

Unspecified contact dermatitis, unspecified cause

6.7

6.0

1CX01, ,

NOMESCO Finland

10.0

6.0

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

6.0

241

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

2.3

6.0

183

C05AA08

ATC

fluocortolone; rectal, topical

1.4

6.0

225

1606

WZA90

NOMESCO Finland

Other medical or dental certificate

1.3

6.0

449

3583

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40760892) CBC W Ordered Manual Differential panel - Blood

1411

8390

2.75

119.15

11.7

6.2

—

(3001604) Monocytes [#/volume] in Blood

1435

8955

2.59

104.04

10.4

5.7

0.58

0.57

e9/l

1.01

1321

7695

(3006315) Basophils [#/volume] in Blood

1435

8968

2.58

103.51

10.4

5.7

0.04

e9/l

0.43

1321

7704

(3013115) Eosinophils [#/volume] in Blood

1467

9281

2.59

102.81

10.8

5.9

0.21

0.18

e9/l

5.08

1359

8103

(40768443) Skin Pathology biopsy report

241

541

4.86

100.92

1.3

1.2

—

(3019198) Lymphocytes [#/volume] in Blood

1458

9266

2.55

100.06

10.5

5.7

1.91

1.96

e9/l

0.22

1366

8168

(3023368) Bacteria identified in Blood by Culture

876

4431

2.57

98.07

6.1

4.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

34.19

94.22

1.0

1.1

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

1562

10434

2.53

93.33

15.5

8.8

4.21

4.03

e9/l

2.13

1443

9070

(3005322) IgE [Units/volume] in Serum or Plasma

323

1004

3.58

86.52

1.6

1.3

511.32

134.17

u/ml

3.91

302

920

(3019069) Monocytes/100 leukocytes in Blood

1330

8515

2.32

83.58

11.5

6.2

8.42

8.46

0.16

1258

7965

(3022096) Basophils/100 leukocytes in Blood

1292

8201

2.30

82.45

11.2

5.9

0.67

0.66

0.05

1221

7643

(3006504) Eosinophils/100 leukocytes in Blood

1320

8466

2.30

82.01

11.2

5.9

3.15

2.78

4.10

1250

7899

(3002030) Lymphocytes/100 leukocytes in Blood

1352

8808

2.29

80.20

11.2

5.9

26.78

28.63

7.45

1286

8269

(3018010) Neutrophils/100 leukocytes in Blood

1331

8667

2.26

78.32

10.7

5.7

57.98

56.81

2.76

1264

8127

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1352

9053

2.19

71.64

9.5

5.9

10.53

11.35

umol/l

1.28

1292

8558

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

141

266

5.58

71.63

2.0

1.7

—

(3005719) IgG [Mass/volume] in Serum or Plasma

356

1315

3.02

71.11

4.0

2.7

10.34

10.52

g/l

0.29

330

1195

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1211

7835

2.15

69.24

8.8

5.7

1.21

mmol/l

2.00

1116

7136

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1289

8624

2.12

66.48

10.4

6.3

1.21

mmol/l

0.87

1086

7333

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

182

461

4.20

64.80

2.6

1.7

1.13

1.18

g/l

0.87

175

435

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

178

444

4.26

64.68

2.6

1.7

0.22

0.23

g/l

0.61

168

421

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

560

2721

2.40

64.07

2.4

1.8

—

(3007853) Bacteria identified in Skin by Aerobe culture

445

1949

2.59

63.68

2.0

1.6

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

166

398

4.42

63.49

2.1

1.6

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

162

387

4.43

62.23

2.1

1.6

—

(3037522) Nuclear Ab [Titer] in Serum

505

2385

2.43

61.27

1.5

1.3

687.04

543.87

titre

0.76

125

491

(3017181) Myelocytes/100 leukocytes in Blood

358

1441

2.76

60.44

6.2

4.0

0.95

0.94

0.02

198

468

(3028026) IgM [Mass/volume] in Serum or Plasma

285

1023

3.04

59.38

2.3

1.8

1.16

1.35

g/l

0.72

262

938

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1767

13688

2.23

57.90

13.6

7.0

80.84

77.76

u/l

1.57

1692

12863

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

145

339

4.50

57.20

7.3

6.4

313.12

511.02

iu/ml

0.51

(3002179) Metamyelocytes/100 leukocytes in Blood

328

1313

2.75

55.72

6.1

3.7

0.69

0.71

0.08

172

406

(3022217) INR in Platelet poor plasma by Coagulation assay

1157

7756

1.98

55.69

13.9

1.19

1.24

inr

1.10

358

2290

(3024561) Albumin [Mass/volume] in Serum or Plasma

1114

7417

1.97

54.21

7.8

4.6

34.82

35.84

g/l

6.98

1031

6899

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

410

1867

2.45

53.26

5.9

4.0

252.63

246.77

u/l

0.31

384

1766

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

304

1202

2.76

52.75

1.9

1.6

—

(3021440) Promyelocytes/100 leukocytes in Blood

331

1375

2.64

52.08

6.5

4.1

0.11

0.10

0.06

170

401

(3011412) CD3 cells [#/volume] in Blood

153

6.08

50.89

2.7

2.4

1.17

1.11

e9/l

0.24

137

(3025159) Blasts/100 leukocytes in Blood

317

1315

2.63

49.91

6.5

4.1

0.71

0.10

0.57

156

343

(3042936) Bacteria identified in Isolate by Culture

477

2395

2.25

49.12

2.6

1.9

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

111

6.95

48.47

2.4

2.5

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

518

2716

2.17

47.76

5.6

3.6

0.81

0.82

mmol/l

1.84

496

2551

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

187

600

3.30

46.79

2.6

1.9

1.16

1.74

ug/l

0.47

166

520

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

104

219

4.93

46.54

2.1

1.6

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

844

5370

1.90

44.67

3.6

2.4

53.89

72.02

u/l

0.64

777

4937

(3036481) Cortisol [Moles/volume] in Serum or Plasma

358

1656

2.37

44.34

3.1

2.0

336.24

377.02

nmol/l

3.48

335

1505

(3004789) Transferrin [Mass/volume] in Serum or Plasma

472

2450

2.16

44.30

3.0

2.3

2.31

2.37

g/l

1.33

435

2260

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

172

5.34

43.92

2.1

1.7

—

(3022948) Iron [Moles/volume] in Serum or Plasma

501

2675

2.11

43.64

3.0

2.3

12.13

13.53

umol/l

4.48

471

2490

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

386

1881

2.26

42.19

2.2

1.7

—

(3013707) Erythrocyte sedimentation rate by Westergren method

1683

13433

1.93

41.95

7.0

3.9

14.54

11.50

mm/h

11.43

1581

12388

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

442

2280

2.16

41.94

3.1

2.4

21.69

23.38

1.59

381

1952

(3003458) Phosphate [Moles/volume] in Serum or Plasma

431

2212

2.17

41.38

8.8

5.5

1.07

1.06

mmol/l

0.60

403

2046

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

382

1870

2.25

41.23

2.1

1.7

—

(3004809) Band form neutrophils/100 leukocytes in Blood

108

259

4.33

41.16

3.5

3.8

2.19

1.46

0.71

230

(3020779) Urea [Moles/volume] in Serum or Plasma

315

1424

2.40

40.91

10.9

7.2

9.49

9.18

mmol/l

0.34

294

1359

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

793

5061

1.86

40.74

2.6

2.1

157.04

228.93

u/l

1.98

748

4747

(3031040) Bacteria [#/volume] in Urine by Automated count

1557

12189

1.85

40.38

6.0

4.2

65.31

1998.17

e6/l

2.69

169

(3013826) Glucose [Moles/volume] in Serum or Plasma

1375

10376

1.80

40.19

6.7

4.5

6.62

6.63

mmol/l

0.08

1310

9617

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

157

497

3.32

40.06

3.2

1.8

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

940

6356

1.81

39.75

4.4

3.4

41.57

51.83

ng/l

0.41

673

4128

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

110

276

4.13

39.49

1.8

1.5

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

107

265

4.19

39.09

3.7

3.6

651.75

2334.00

u/ml

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

179

4.95

39.00

2.0

1.6

—

(3023520) Reticulocytes [#/volume] in Blood

303

1376

2.38

38.85

3.5

2.7

69.95

69.47

e9/l

0.08

235

1042

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

11.61

38.75

1.6

1.4

33.71

24.00

u/ml

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

111

289

3.98

37.89

2.0

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

111

289

3.98

37.89

2.0

1.6

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

156

511

3.20

37.62

3.1

2.8

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

205

4.58

37.53

1.8

1.5

—

(3037467) Urinalysis macro (dipstick) panel - Urine

1598

12740

1.82

37.51

6.4

4.1

—

(3018418) pH of Serum or Plasma

782

5077

1.82

37.29

5.9

3.8

7.40

0.14

173

973

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

163

5.05

37.19

2.1

1.7

—

(3027945) Reticulocytes/100 erythrocytes in Blood

371

1868

2.17

37.08

3.4

2.9

1.82

1.76

0.47

331

1665

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

210

4.47

36.42

1.8

1.5

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

712

4546

1.82

35.54

3.4

3.0

1515.92

1337.82

ng/l

0.44

605

3831

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

118

5.73

35.42

1.6

1.7

—

(3007164) IgA [Mass/volume] in Serum or Plasma

602

3662

1.87

35.06

1.9

1.4

2.28

2.32

g/l

0.24

415

2239

(3009343) pH of Capillary blood

250

1089

2.45

35.01

5.6

3.8

7.41

0.34

122

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

244

1053

2.47

34.87

5.5

3.8

1.66

mmol/l

0.00

179

769

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

251

1101

2.44

34.61

5.7

3.8

5.11

5.15

kpa

0.25

237

1058

(3015171) Extractable nuclear Ab [Units/volume] in Serum

173

631

2.88

34.54

1.3

1.2

1.99

0.93

u/ml

0.26

(3020630) Protein [Mass/volume] in Serum or Plasma

277

1274

2.33

34.31

4.3

2.8

65.58

66.47

g/l

1.05

253

1162

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

119

350

3.53

34.04

4.2

3.5

59.94

56.59

1.58

119

350

(3026493) Urate [Moles/volume] in Serum or Plasma

683

4355

1.81

33.97

3.7

2.6

3086.09

5030.93

umol/l

0.76

606

3840

(3000494) Fungus identified in Specimen by Culture

365

1904

2.09

33.01

1.9

1.4

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1036

7484

1.70

32.76

2.8

2.2

75.54

76.42

nmol/l

0.45

953

6751

(3004588) Protein electrophoresis panel - Serum or Plasma

235

1025

2.44

32.75

3.5

2.6

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

243

3.99

32.40

1.8

1.5

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

113

336

3.48

31.78

3.8

3.3

4.58

3.93

e9/l

1.80

113

336

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

698

4559

1.76

31.55

2.8

2.2

3.17

2.91

mg/l

1.96

593

3879

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

620

3940

1.78

30.66

2.0

1.8

1.11

1.19

mg/l

0.34

490

2980

(21494814) CD8 cells/100 lymphocytes in Specimen

7.67

30.61

2.0

1.9

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

149

536

2.90

30.47

1.9

1.6

203.33

90.59

titre

0.97

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

9.36

30.07

2.1

—

(3030467) Casts [#/volume] in Urine by Automated count

726

4852

1.72

29.94

4.2

3.0

0.43

0.45

e6/l

0.08

600

3645

(3000850) Epithelial cells [#/volume] in Urine

586

3689

1.79

29.79

3.5

2.5

5.60

6.59

e6/l

1.05

544

3299

(3017143) Hepatitis C virus Ab [Presence] in Serum

412

2332

1.93

29.34

2.0

1.6

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

312

1602

2.10

29.22

3.1

2.4

0.21

g/l

0.25

283

1507

(3035350) Ketones [Presence] in Urine by Test strip

1186

9064

1.63

28.78

5.0

3.5

0.00

estimate

0.99

272

1837

(3021589) Normoblasts [#/volume] in Blood

1086

8140

1.63

28.36

17.3

9.0

0.00

e9/l

0.44

941

6608

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

136

4.81

28.34

1.8

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

136

4.81

28.34

1.8

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

136

4.81

28.34

1.8

1.5

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

115

5.15

27.83

2.1

1.5

—

(3026008) Bacteria identified in Urine by Culture

798

5556

1.67

27.79

3.9

2.9

—

(3021601) Nitrite [Presence] in Urine by Test strip

1180

9055

1.62

27.78

6.4

4.7

0.00

estimate

0.50

273

1740

(3018677) aPTT in Platelet poor plasma by Coagulation assay

441

2596

1.86

27.70

2.4

2.3

29.54

29.61

0.09

428

2525

(3009261) Glucose [Presence] in Urine by Test strip

1186

9151

1.61

27.00

5.1

3.5

0.00

estimate

0.80

262

1694

(40758558) Short blood count panel - Blood

683

4605

1.69

26.67

11.7

6.6

—

(3018095) Leukocytes [#/volume] in Urine

883

6372

1.62

26.32

4.8

3.5

62.27

98.32

e6/l

1.01

666

4333

(36304419) Bacteria [Presence] in Urine

699

4772

1.67

25.88

4.1

2.9

—

(3048689) Calprotectin [Mass/mass] in Stool

397

2306

1.87

25.85

3.2

2.4

131.39

122.54

ug/g

0.22

308

1823

(3015736) pH of Urine

981

7289

1.60

25.75

4.4

3.2

5.83

5.89

0.21

573

(3008757) Leukocyte morphology finding [Identifier] in Blood

186

4.02

25.69

4.2

4.6

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1101

8410

1.59

25.67

3.7

2.8

154.47

108.96

ug/l

2.07

1018

7790

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

143

553

2.69

25.49

1.8

1.6

2.57

0.06

iu/ml

0.61

110

(3026782) Osmolality of Urine

549

3535

1.73

25.20

4.0

2.8

502.38

543.61

mosm/kgh2o

4.56

488

3039

(3002582) Erythrocytes [#/volume] in Urine

758

5312

1.64

25.17

4.3

3.1

40.47

84.41

e6/l

1.50

630

4026

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

114

4.92

25.10

3.1

2.6

0.23

0.20

e9/l

0.33

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

255

3.51

25.03

1.9

1.4

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

204

3.82

24.89

1.9

1.6

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

204

3.82

24.89

1.9

1.6

—

(3037756) Immunofixation for Serum or Plasma

311

3.25

24.88

2.2

1.6

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

119

4.80

24.82

3.0

2.5

597.42

460.67

e6/l

1.12

100

(40760888) Immunoglobulin light chains.free panel - Serum

100

322

3.20

24.78

5.0

4.2

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

120

431

2.88

24.60

4.9

4.0

5.82

1.77

ratio

0.51

(3017354) Segmented neutrophils/100 leukocytes in Blood

153

4.27

24.52

3.3

58.31

55.79

0.37

133

(3034860) Kappa light chains.free [Mass/volume] in Serum

122

443

2.85

24.51

4.9

4.0

80.99

69.68

mg/l

0.12

372

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

122

446

2.83

24.21

4.9

4.0

43.90

80.99

mg/l

0.59

374

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

119

434

2.84

23.72

2.1

12.18

11.12

mg/l

0.41

110

397

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

165

708

2.43

23.70

2.1

1.8

1.69

1.50

g/l

1.36

148

617

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

41.88

23.62

1.1

1.0

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

167

722

2.42

23.59

6.6

4.1

24.77

mmol/l

0.01

155

680

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

123

458

2.78

23.58

1.4

1.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

279

1483

2.00

23.54

1.5

1.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

109

382

2.95

23.36

1.5

1.6

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

8.04

23.03

1.1

1.91

0.21

u/ml

0.92

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

114

413

2.85

23.01

1.4

1.2

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2065

18679

1.98

23.00

26.7

12.6

21.01

22.73

mg/l

2.09

1827

14509

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

208

1000

2.19

22.89

1.6

1.5

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

322

3.10

22.85

1.6

1.2

17.00

4.43

u/ml

0.42

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

6.32

22.74

2.2

2.3

799.00

43669.18

u/ml

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

822

5989

1.58

22.66

4.7

3.2

2.33

2.35

mmol/l

4.60

730

5310

(3019309) Folate [Moles/volume] in Red Blood Cells

485

3097

1.72

22.65

1.8

1.7

1267.12

1174.14

nmol/l

1.29

368

2359

(3003396) Base excess in Arterial blood by calculation

324

1842

1.88

22.35

7.9

7.3

1.35

1.08

mmol/l

0.64

252

1446

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

106

376

2.91

22.24

1.7

1.4

—

(3044640) Blood type and Crossmatch panel - Blood

801

5824

1.57

22.17

3.2

2.3

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

114

425

2.77

21.81

1.5

1.2

23.63

8.06

u/ml

0.90

(3019060) Gas panel - Arterial blood

210

1033

2.14

21.79

5.2

4.7

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

113

421

2.77

21.65

1.5

1.2

13.16

2.91

u/ml

0.55

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

480

3090

1.70

21.65

1.3

33.09

31.45

iu/ml

0.10

156

987

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

182

3.76

21.59

1.4

1.2

—

(3022313) Gas panel - Capillary blood

176

809

2.27

21.59

6.8

3.9

—

(3016502) Oxygen saturation in Arterial blood

293

1633

1.91

21.43

8.3

7.7

95.40

95.72

0.33

277

1567

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

633

4384

1.61

21.39

3.1

2.2

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

458

2922

1.71

21.32

1.3

1.2

18.15

11.76

u/ml

0.28

169

1151

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

118

454

2.69

21.25

1.6

1.2

30.91

50.24

u/ml

0.55

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

321

1848

1.86

21.22

8.1

7.2

5.05

5.10

kpa

0.45

303

1753

(3027801) Oxygen [Partial pressure] in Arterial blood

321

1849

1.85

21.19

8.1

7.2

12.27

12.50

kpa

0.31

301

1754

(3048929) Epstein Barr virus Ab [Presence] in Serum

157

693

2.36

21.16

1.4

1.2

—

(3033658) Prothrombin time (PT) actual/Normal

642

4479

1.60

20.97

5.6

4.0

91.56

91.02

0.21

622

4366

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

104

379

2.83

20.77

1.7

1.4

—

21.82

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

188

3.64

20.61

1.7

1.6

61.17

62.03

0.06

120

(3029937) Albumin [Presence] in Urine by Test strip

687

4892

1.58

20.48

5.7

3.8

0.00

estimate

1.08

255

1695

(40761535) Cells panel - Urine sediment

255

1385

1.95

20.10

4.7

3.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

5.20

20.06

2.2

1.6

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

150

3.94

20.04

1.5

5.68

7.10

g/l

1.54

105

(3024139) IgG subclass 3 [Mass/volume] in Serum

150

3.94

20.04

1.5

0.38

0.40

g/l

0.17

107

(3028192) IgG subclass 2 [Mass/volume] in Serum

150

3.94

20.04

1.5

2.20

2.95

g/l

2.01

107

(3008152) Bicarbonate [Moles/volume] in Arterial blood

198

983

2.11

20.03

7.8

6.7

24.60

24.52

mmol/l

0.12

189

925

(3028433) Virus identified in Specimen by Culture

6.01

19.97

1.2

1.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

105

393

2.75

19.95

1.6

1.3

341.09

257.01

u/ml

1.39

239

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

4.76

19.88

2.1

1.5

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

258

3.18

19.81

1.5

1.7

0.47

0.82

g/l

3.26

197

(3012544) pH of Venous blood

280

1576

1.88

19.81

5.1

4.1

7.41

7.37

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

156

707

2.29

19.78

2.1

2.0

38.39

38.86

u/l

0.10

140

631

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

611

4265

1.59

19.71

1.4

1.3

1.20

1.52

u/ml

0.41

157

1114

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

346

2.85

19.58

1.8

1.4

118.50

121.93

u/ml

0.09

(4062490) Immunoglobulin typing, IgG

153

3.86

19.50

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

5.13

19.31

2.3

1.6

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1095

8704

1.49

19.16

3.3

2.5

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

272

1539

1.87

18.90

5.5

4.1

5.78

5.83

kpa

0.31

265

1494

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

151

692

2.26

18.65

2.4

1.9

—

(3002032) Base excess in Venous blood by calculation

270

1531

1.86

18.62

5.6

4.1

1.91

1.89

mmol/l

0.03

232

1250

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

907

6972

1.50

18.54

5.4

3.6

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

503

3397

1.61

18.47

1.9

1.6

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

534

3685

1.58

17.84

1.7

1.6

82500449.02

23995241.54

pmol/l

0.78

440

3084

(3020891) Body temperature

137

614

2.31

17.83

6.0

4.4

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

6.03

17.78

1.5

1.7

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

193

992

2.03

17.76

1.9

1.6

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

265

1519

1.84

17.63

9.1

7.9

118.76

121.39

g/l

1.28

258

1473

(1616796) Gas panel - Central venous blood

378

2.66

17.59

4.9

3.5

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

139

631

2.28

17.56

2.1

1.8

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

123

530

2.39

17.51

2.6

3.4

3.79

3.55

g/l

0.91

115

504

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

113

470

2.48

17.37

2.1

1.6

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

790

5967

1.49

17.30

5.0

3.2

32.05

31.66

u/l

0.09

744

5671

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

299

1788

1.77

17.27

4.4

3.1

—

(3019225) pH of Specimen

286

1690

1.79

17.20

6.6

3.9

—

(4035726) Immunohistochemistry procedure

262

1511

1.83

17.07

1.5

1.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

590

4202

1.54

17.03

4.7

3.5

—

(3025941) Bacteria identified in Stool by Culture

197

1039

1.98

16.85

1.4

1.2

—

(3000991) Gas panel - Venous blood

249

1422

1.84

16.73

10.0

8.4

—

(3021960) Folate [Moles/volume] in Serum or Plasma

561

3965

1.55

16.72

1.7

1.5

19.38

20.46

nmol/l

0.91

494

3382

(3011897) Casein IgE Ab [Units/volume] in Serum

15.16

16.65

1.4

1.0

5.92

0.01

u/ml

0.56

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

548

3884

1.54

16.03

1.7

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

4.53

15.89

2.0

1.5

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

4.53

15.89

2.0

1.5

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

897

7040

1.45

15.75

2.2

1.9

98.03

95.89

pmol/l

0.64

532

3631

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

370

2.58

15.71

1.5

1.4

—

(3042631) Mycobacterium sp identified in Specimen

210

3.11

15.45

3.5

2.8

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

4.91

15.21

2.1

1.6

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

4.91

15.21

2.1

1.6

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

4.91

15.21

2.1

1.6

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

262

2.84

15.06

2.1

1.7

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

571

4131

1.51

15.04

2.2

1.9

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1644

14504

1.46

14.72

4.9

4.0

14.83

14.70

pmol/l

1.23

1498

13236

(40767503) Oxygen content in Capillary blood by calculation

346

2.57

14.72

3.0

2.4

16.22

16.45

0.16

169

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

120

552

2.24

14.71

2.1

2.4

188.26

468.89

ug/l

1.99

109

514

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

6.15

14.66

1.2

1.4

—

(3022145) Colonoscopy Study observation

300

1876

1.69

14.66

1.4

1.3

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

224

1289

1.82

14.65

5.1

3.8

100.92

83.33

ng/l

1.53

193

1128

(3012501) Base excess in Blood by calculation

390

2.47

14.56

5.2

4.0

2.20

2.54

mmol/l

0.68

258

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

311

1970

1.67

14.46

4.3

3.0

8.84

7.82

umol/l

0.30

273

1694

(3014111) Lactate [Moles/volume] in Serum or Plasma

247

1469

1.76

14.45

7.8

7.0

1.51

1.35

mmol/l

0.98

241

1427

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

100

429

2.39

14.41

1.6

1.3

—

(3013512) EKG study

652

4880

1.47

14.40

4.5

3.6

—

(3007566) Smooth muscle Ab [Titer] in Serum

108

480

2.31

14.36

1.3

88.75

86.98

titre

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

425

2910

1.56

14.34

3.2

2.6

1.03

1.34

e6/l

0.70

269

1603

(3023419) Bacteria identified in Sputum by Culture

247

2.85

14.32

4.7

2.6

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

229

1336

1.79

14.30

3.5

2.6

63.16

68.02

ml/min/173m2

1.00

101

518

(3019550) Sodium [Moles/volume] in Serum or Plasma

2030

18789

1.66

14.00

26.8

14.4

139.36

139.66

mmol/l

6.06

1997

18273

(3034770) Mitochondria Ab [Titer] in Serum

108

487

2.28

13.89

1.2

1.3

—

1073.13

—

(3017732) Neutrophils [#/volume] in Blood

216

1251

1.80

13.81

4.0

2.6

7.17

4.94

e9/l

0.80

164

1028

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

104

3.90

13.79

1.5

1.1

19.43

3.78

u/ml

—

(3004616) Nuclear Ab [Presence] in Serum

182

3.13

13.77

1.5

1.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

316

2.59

13.74

2.2

1.6

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

2032

18839

1.65

13.59

27.0

14.5

3.96

3.95

mmol/l

0.54

2000

18289

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

4.45

13.56

1.5

1.2

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

107

3.79

13.26

1.2

1.0

8.78

0.48

u/ml

1.88

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

112

3.71

13.20

1.4

1.1

78.50

66.67

u/ml

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1408

12192

1.40

13.14

4.6

3.0

53.82

43.83

u/l

3.59

1326

11428

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

120

581

2.12

12.97

3.9

2.6

3.42

3.59

g/l

0.81

112

529

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

120

582

2.12

12.91

3.9

2.6

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

120

582

2.12

12.91

3.9

2.6

7.42

7.43

g/l

0.02

112

529

(3000060) B lymphocytes [#/volume] in Blood

5.05

12.89

2.0

2.7

1488.00

164.64

e6/l

0.51

(3016650) Hepatitis A virus Ab [Presence] in Serum

310

2.53

12.74

1.1

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

457

3258

1.50

12.65

4.6

3.5

236.85

432.53

ng/l

1.32

326

2430

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

231

1401

1.72

12.58

6.6

3.4

1.22

1.23

mmol/l

1.26

203

1214

(3000475) Leukocytes [#/volume] in Synovial fluid

380

2.37

12.53

1.9

1.7

25193.71

13854.72

e6/l

0.72

284

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

107

3.69

12.49

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

107

3.69

12.49

1.1

1.0

—

(40761536) Microorganisms panel - Urine sediment

260

1632

1.67

12.45

6.4

3.6

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

208

1228

1.76

12.45

2.5

2.4

32.58

22.24

au/ml

0.58

(3006922) Hepatitis E virus Ab [Presence] in Serum

117

3.55

12.40

1.1

—

(3024354) Oxygen [Partial pressure] in Venous blood

215

1285

1.74

12.33

5.7

3.6

4.79

4.60

kpa

0.72

209

1248

(3021788) Differential panel - Synovial fluid

294

2.53

12.09

1.9

1.6

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

300

2.52

12.09

1.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

171

3.03

11.93

1.9

1.5

35.80

19.60

iu/ml

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

112

546

2.10

11.91

3.4

2.6

3.00

3.04

g/l

0.14

104

494

(3035637) Corticotropin [Mass/volume] in Plasma

211

2.79

11.73

1.6

1.5

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

200

2.84

11.72

1.7

1.3

0.66

60.42

u/ml

—

(3037121) Protein [Mass/volume] in Urine

125

639

2.01

11.70

4.2

3.2

0.31

0.26

g/l

0.22

265

(3020874) Milk IgE Ab [Units/volume] in Serum

3.72

11.67

1.4

1.0

17.96

1.31

u/ml

1.01

(40768804) Tissue Pathology biopsy report

890

7260

1.37

11.42

2.2

2.0

—

(40768797) Stomach Pathology biopsy report

344

2359

1.54

11.34

1.3

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

9.65

11.23

1.2

3.3

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

189

1118

1.75

11.23

1.3

45.68

43.33

au/ml

—

(3019150) Specific gravity of Urine by Refractometry

532

3991

1.43

11.17

5.2

3.8

1.02

kg/l

0.09

596

(3003181) Sodium [Moles/volume] in Urine

282

2.49

11.10

1.3

1.4

63.87

66.85

mmol/l

0.26

233

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

102

496

2.11

10.94

3.2

2.8

1.16

1.17

g/l

0.01

440

(4200892) Spirometry reversibility

194

1168

1.72

10.83

1.5

1.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

3.99

10.76

3.5

4.9

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2081

19601

1.61

10.75

27.8

14.6

80.03

74.61

umol/l

5.67

2081

19595

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

105

3.47

10.57

2.9

2.6

35.50

41.46

1.00

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

154

874

1.82

10.53

11.0

9.7

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

107

541

2.03

10.35

4.0

2.7

10.09

10.21

g/l

0.07

487

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

3.54

10.32

1.1

1.2

1.40

16.00

u/ml

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

104

521

2.04

10.32

3.5

3.7

0.35

0.36

u/ml

0.05

291

(3021901) Oxygen saturation in Capillary blood

286

2.42

10.31

3.1

2.6

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

274

2.45

10.30

1.4

27.45

25.76

u/l

0.14

224

(3012516) Albumin [Mass/volume] in Urine

615

4790

1.39

10.28

3.7

3.3

742.09

227.94

mg/l

1.28

388

3040

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

441

2.13

10.25

3.1

2.7

0.00

0.02

g/l

1.09

410

(21494890) Protein electrophoresis panel - 24 hour Urine

154

2.96

10.20

2.6

2.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

251

2.51

10.20

1.3

1.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1447

12831

1.34

10.17

3.6

3.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

3.63

10.09

1.6

1.4

—

(3000012) Reticulocyte production index

229

2.57

10.05

2.7

2.0

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

172

1023

1.74

10.04

10.0

9.1

1.40

1.34

0.41

166

1016

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

4.64

10.00

3.6

2.3

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

218

2.61

9.99

2.5

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

3.59

9.93

1.6

1.4

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

136

3.05

9.82

1.7

1.4

30.04

31.60

0.09

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

338

2.26

9.74

1.9

1.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

204

2.64

9.68

1.2

—

(3017704) Immunofixation for Urine

3.60

9.66

1.3

1.5

—

(3009508) Creatinine [Moles/volume] in Urine

673

5366

1.36

9.61

3.7

3.3

7.09

7.58

mmol/l

2.02

558

4575

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

501

2.02

9.57

5.7

5.8

1.55

1.46

mg/l

0.48

464

(3045142) Bone marrow Pathology biopsy report

188

2.70

9.56

1.5

1.4

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

169

1015

1.72

9.53

10.3

9.2

0.73

0.69

0.59

163

1009

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

260

2.42

9.49

1.2

—

(3047181) Lactate [Moles/volume] in Blood

101

517

2.00

9.46

6.4

5.7

1.24

1.27

mmol/l

0.16

445

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1851

17136

1.40

9.34

21.3

11.8

82.98

83.88

ml/min/173m2

0.84

1607

14012

(3008898) HLA-B27 [Presence]

123

678

1.86

9.26

1.1

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1851

17152

1.40

9.16

5.9

4.7

1.94

2.13

mu/l

0.69

1710

15805

(3041096) Erythrocytes [Presence] in Urine by Automated

629

4994

1.36

9.15

4.7

3.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

110

587

1.92

9.15

1.6

—

(3018405) Lactate [Moles/volume] in Arterial blood

106

559

1.94

9.13

4.7

3.9

1.35

1.38

mmol/l

0.10

101

551

(36660697) Celiac disease serology panel - Serum

227

1492

1.58

8.98

1.2

—

(3020682) Albumin/Creatinine [Ratio] in Urine

632

5034

1.35

8.98

4.4

3.9

11.23

7.96

mg/mmol

0.92

394

3164

(3003888) Timothy IgE Ab [Units/volume] in Serum

333

2.20

8.82

1.1

1.0

12.04

5.22

u/ml

1.51

170

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

377

2763

1.44

8.80

3.5

2.8

3.88

2.68

e6/l

1.12

219

1469

(3004119) Hemoglobin [Mass/volume] in Venous blood

160

968

1.70

8.80

4.6

3.2

125.52

128.63

g/l

0.96

155

943

(3011436) Histone Ab [Units/volume] in Serum

8.63

8.79

1.3

1.0

—

u/ml

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

101

531

1.94

8.79

1.2

1.1

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

108

581

1.90

8.78

2.5

3.2

94.73

91.34

0.91

101

562

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

355

2.15

8.68

1.6

1.2

44.50

49.07

u/ml

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

425

3194

1.41

8.60

4.2

2.9

2.45

mmol/l

0.19

384

2810

(3009214) Lutropin [Units/volume] in Serum or Plasma

106

572

1.89

8.54

1.6

1.5

12.37

9.48

u/l

1.22

458

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

138

2.86

8.39

1.9

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

155

2.74

8.36

1.4

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

321

2.18

8.35

4.1

3.3

94.85

1209.58

u/ml

0.79

300

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2077

19730

1.52

8.33

18.3

9.5

26.56

25.69

u/l

1.27

2029

19029

(3042733) HLA Ab [Presence] in Serum

4.00

8.33

5.4

4.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

112

3.07

8.28

1.3

—

(40761511) CBC panel - Blood by Automated count

2060

19548

1.49

8.18

23.2

11.9

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

475

1.95

8.11

1.3

1.4

279.92

292.98

ug/g

0.20

255

(3014765) Yersinia sp identified in Stool by Organism specific culture

533

1.90

8.05

1.2

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

224

2.40

8.03

1.5

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

225

2.39

7.95

1.5

1.4

—

(3008536) Aspergillus sp Ab [Presence] in Serum

6.10

7.84

1.9

1.5

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

100

3.13

7.83

1.3

1.0

1.32

0.19

u/ml

0.96

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1763

16331

1.33

7.82

6.3

5.3

39.55

39.34

mmol/mol

0.39

1620

15151

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

138

2.78

7.81

1.6

1.2

3.02

0.83

u/ml

0.42

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

227

2.37

7.80

1.5

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

3.25

7.80

1.3

1.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

3.25

7.80

1.3

1.7

—

(42529406) Shigella sp [Presence] in Stool by Culture

540

1.87

7.75

1.2

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

379

2.04

7.71

1.1

1.81

2.28

u/ml

0.20

187

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

312

2.15

7.70

4.2

2.8

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

3.74

7.63

6.0

4.5

—

(3044941) Cell count panel - Synovial fluid

256

2.26

7.54

1.7

1.4

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

257

2.25

7.47

1.2

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

198

1316

1.55

7.47

3.7

2.7

178.43

196.94

ng/l

0.27

178

1196

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

205

1377

1.54

7.37

2.3

2.4

5.87

7.38

ug/l

0.84

176

1205

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

106

602

1.80

7.31

1.3

1.4

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

394

1.99

7.30

1.2

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

155

2.61

7.28

1.2

66.42

57.58

u/l

0.26

143

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

3.50

7.27

1.6

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

3.50

7.27

1.6

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

223

2.32

7.19

1.5

1.4

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

4.50

7.18

1.5

1.4

29.45

22.54

0.31

(3005988) Vibrio sp identified in Specimen by Organism specific culture

224

2.31

7.12

1.5

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

224

2.31

7.12

1.5

1.4

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

212

2.34

7.08

1.1

—

(40768446) Kidney Pathology biopsy report

3.78

7.08

2.0

1.7

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

413

1.95

7.05

3.3

2.8

0.00

g/l

-0.00

384

(3008401) Mugwort IgE Ab [Units/volume] in Serum

324

2.07

7.02

1.1

1.0

2.91

1.02

u/ml

0.88

130

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

118

2.82

7.01

1.2

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

414

1.94

7.00

3.3

2.8

0.00

g/l

-0.00

384

(3007930) Methemoglobin/Hemoglobin.total in Blood

110

640

1.75

7.00

6.7

4.8

1.03

0.90

1.22

104

594

(3039000) Anion gap in Blood

359

2.01

6.97

7.6

6.5

11.03

11.21

mmol/l

0.15

319

(3018572) Chloride [Moles/volume] in Blood

360

2.00

6.92

7.7

6.5

104.95

105.33

mmol/l

0.28

320

(3010144) Erythrocytes [#/volume] in Synovial fluid

142

2.63

6.88

1.4

1.3

270189.96

86756.82

e6/l

0.47

(3009466) Valproate [Moles/volume] in Serum or Plasma

273

2.15

6.88

5.3

5.2

375.58

370.68

umol/l

0.09

237

(3024471) HLA-A [Type]

3.57

6.87

1.0

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

160

2.53

6.85

3.7

2.6

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

3.20

6.84

1.7

1.5

13.99

22.12

umol/l

1.28

(3044290) Cell count panel - Cerebral spinal fluid

362

1.99

6.82

1.7

1.6

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

463

1.87

6.72

3.3

2.6

37.36

37.62

g/l

0.16

410

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

301

2220

1.41

6.71

1.9

1.7

1.47

1.44

0.25

263

1960

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

3.23

6.70

1.4

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

257

2.17

6.65

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

277

2.12

6.64

1.2

1.1

—

(44813793) Dust mix specific IgE antibody measurement

105

2.88

6.63

1.1

1.0

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

237

1679

1.46

6.58

3.1

2.2

35.57

66.75

u/l

0.55

204

1431

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

109

645

1.72

6.56

6.7

4.8

1.87

1.59

0.69

102

597

(3020876) Protein [Mass/time] in 24 hour Urine

177

2.40

6.46

2.6

2.4

1.45

1.46

g/24h

0.01

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

159

2.48

6.44

1.5

1.4

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

174

1165

1.53

6.37

3.0

3.2

4.46

4.55

pmol/l

0.50

155

1037

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

9.27

6.28

2.2

7.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

143

2.54

6.28

1.2

1.1

—

(3036489) Thrombin time

115

700

1.68

6.25

2.4

2.7

21.10

21.43

0.29

100

615

(3006184) Hemoglobin [Mass/volume] in Capillary blood

374

1.93

6.24

2.7

2.3

126.47

131.27

g/l

0.85

279

(3001964) Herpes simplex virus Ag [Presence] in Specimen

3.68

6.20

1.6

1.7

—

(3023183) Ammonium ion [Moles/volume] in Plasma

347

1.96

6.19

2.9

3.2

29.92

35.49

umol/l

1.59

318

(3016018) Differential panel - Cerebral spinal fluid

181

2.34

6.17

1.6

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

127

2.62

6.14

1.3

1.2

—

(4034850) Laboratory test

560

1.75

6.10

12.0

9.9

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

349

1.95

6.09

1.3

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

349

1.95

6.09

1.3

1.2

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

3.30

5.86

2.4

3.6

—

74.83

—

(3045414) Leukocytes [Presence] in Urine

130

832

1.60

5.82

2.0

1.9

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

313

1.97

5.80

1.0

1.1

5.99

0.96

u/ml

1.33

144

(3028679) Herpes simplex virus Ab [Presence] in Serum

102

2.77

5.79

1.2

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

3.16

5.74

1.6

1.3

3.14

2.64

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

283

2122

1.38

5.71

4.7

4.3

32.01

32.41

0.23

214

1464

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

126

2.56

5.71

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

126

2.56

5.71

1.3

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

232

1682

1.42

5.70

4.9

4.1

17.84

20.77

ug/l

0.15

190

1364

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

6.12

5.69

2.7

2.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

277

2076

1.38

5.61

10.7

6.5

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

530

1.73

5.56

1.2

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

264

2.03

5.49

1.1

1.0

11.16

2.04

u/ml

1.89

112

(21494434) Karyotype in Bone marrow

147

2.40

5.47

1.3

1.2

—

(3052851) Hemolysis interference index of Serum or Plasma

533

1.72

5.45

3.1

—

(3009871) Measles virus Ab [Titer] in Serum

3.48

5.45

1.6

1.7

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

3.25

5.45

3.4

2.5

9.47

9.73

mg/l

0.06

(3000492) Spirometry study

234

1719

1.40

5.34

1.5

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

155

2.34

5.34

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

11.29

5.29

1.8

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

6.69

5.25

2.8

1.6

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

3.49

5.17

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

3.35

5.16

1.2

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

446

1.75

5.07

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

2.91

5.03

1.5

1.4

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

10.03

5.02

1.7

1.0

—

(3045424) Erythrocytes [Presence] in Urine

302

1.91

4.99

1.7

1.5

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

240

2.02

4.95

1.0

1.1

7.12

4.45

u/ml

0.56

(3013005) Retinol [Moles/volume] in Serum or Plasma

2.87

4.92

2.9

2.2

1.93

1.92

umol/l

0.03

(40757494) Bilirubin.total [Moles/volume] in Blood

2.87

4.92

2.5

1.7

15.90

38.96

umol/l

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

398

1.78

4.91

1.7

1.6

33.00

25.00

e6/l

0.16

315

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

398

1.78

4.91

1.7

1.6

87.79

1142.58

e6/l

1.43

330

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

2.68

4.91

1.1

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.35

4.88

1.2

—

(3002385) Erythrocyte distribution width [Ratio]

1738

16380

1.25

4.87

27.8

15.3

15.22

14.70

3.10

1724

16063

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

514

1.68

4.81

1.1

2.52

4.06

u/ml

—

(40768441) Liver Pathology biopsy report

125

2.42

4.80

1.9

1.5

—

(3024932) HLA-DR beta [Type]

3.08

4.79

1.2

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

3.42

4.74

1.2

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

2.96

4.71

1.6

2.0

117.63

129.98

umol/l

—

(3014271) Vancomycin [Susceptibility]

2.77

4.61

3.9

2.7

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

2.92

4.60

3.2

4.2

7.70

8.69

mg/l

0.40

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.99

4.55

1.2

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

2.99

4.55

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

4.54

4.55

1.4

—

(3047189) Immunofixation for 24 hour Urine

2.82

4.55

3.2

1.7

—

(3019977) pH of Arterial blood

2.73

4.51

2.3

3.1

7.42

7.43

—

(3044889) 12 lead EKG panel

1336

12320

1.20

4.41

4.5

3.5

—

(3010838) Calcium [Moles/time] in 24 hour Urine

316

1.82

4.38

2.0

1.9

4.49

5.15

mmol/24h

0.95

274

(40768795) Lymph node Pathology biopsy report

163

2.16

4.37

1.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.60

4.31

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

161

1152

1.43

4.30

2.0

2.1

11.69

12.08

nmol/l

0.22

144

1025

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

3.97

4.29

1.0

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

2.92

4.17

3.3

2.8

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

5.26

4.14

1.3

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

544

1.60

4.13

1.3

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

4.35

4.12

1.3

1.1

77.38

92.77

0.76

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

2.72

4.08

1.3

1.7

—

943108.33

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

8.02

4.06

7.0

7.6

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

8.02

4.06

1.0

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

3.21

4.05

1.2

1.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1837

17523

1.23

4.04

5.1

4.2

5.92

5.85

mmol/l

1.01

1673

16011

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

2.77

4.02

4.5

2.3

17.37

17.36

ug/l

0.00

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

163

2.10

3.98

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

131

2.23

3.93

1.3

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.14

3.93

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

151

1087

1.42

3.92

1.5

1.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

489

1.62

3.90

1.1

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.46

3.88

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

6.02

3.81

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

186

1394

1.36

3.81

1.3

1.2

106.24

154.51

iu/ml

0.96

513

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

2.54

3.80

1.1

1.2

—

(3010813) Leukocytes [#/volume] in Blood

2153

20978

1.38

3.79

36.4

18.7

6.97

6.67

e9/l

4.08

2118

20362

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

265

1.83

3.78

1.3

1.2

46.06

43.93

u/l

0.03

221

(3009542) Hematocrit [Volume Fraction] of Blood

2150

20945

1.38

3.78

36.4

18.8

39.55

40.21

1.93

2037

19653

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

4.60

3.74

1.3

—

(3007461) Platelets [#/volume] in Blood

2151

20964

1.37

3.69

36.5

18.7

255.73

253.39

e9/l

0.81

2121

20403

(3024731) MCV [Entitic volume]

2152

20978

1.37

3.67

36.2

18.6

91.00

90.59

3.71

2133

20680

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

261

1.82

3.65

1.8

2.7

3.85

21.85

u/ml

0.67

256

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

3.12

3.65

1.1

1.2

—

(3026361) Erythrocytes [#/volume] in Blood

2152

20981

1.37

3.63

36.4

18.7

4.39

4.49

e12/l

17.27

2119

20366

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

4.78

3.55

1.0

1.2

—

(3035941) MCH [Entitic mass]

2151

20979

1.36

3.54

36.2

18.6

30.21

30.18

0.41

2133

20679

(3000963) Hemoglobin [Mass/volume] in Blood

2152

20991

1.36

3.53

36.5

18.8

131.84

134.85

g/l

17.59

2134

20688

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

151

2.07

3.52

1.3

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

151

2.07

3.52

1.2

1.4

—

(3030313) Adrenal Ab [Titer] in Serum

5.31

3.51

1.6

1.1

—

(3019174) dRVVT (LA screen)

5.31

3.51

1.3

1.2

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

10.02

3.50

1.5

1.0

—

(3044009) aPTT.lupus sensitive (LA screen)

5.02

3.37

1.3

—

(3036670) Protein [Mass/volume] in Synovial fluid

2.84

3.35

1.5

1.2

41.90

38.89

g/l

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

247

1.80

3.33

1.7

1.5

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

2.72

3.32

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

2.48

3.29

2.6

2.4

—

(3004451) EKG impression Narrative

2.55

3.29

1.2

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

8.59

3.26

2.2

1.7

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

2.59

3.21

1.1

1.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

230

1.80

3.12

1.0

1.49

0.06

u/ml

0.76

(3032057) Clostridioides difficile [Presence] in Stool

3.44

3.10

2.0

1.9

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1787

17132

1.19

3.05

4.3

3.7

1.33

1.26

mmol/l

3.60

1638

15752

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

7.52

3.05

5.8

2.3

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

160

1.95

3.04

7.6

3.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

661

1.46

3.03

1.6

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

5.85

3.02

3.3

2.8

2.63

3.92

mg/l

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.35

3.01

1.9

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

363

1.61

2.99

1.9

1.3

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

2.76

2.98

1.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

10.02

2.98

1.0

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

2.41

2.97

1.1

190.29

223.05

iu/ml

0.23

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.64

2.96

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

205

1.82

2.95

2.7

2.4

23.82

24.40

mg/l

0.03

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

311

2585

1.23

2.93

2.2

2.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

2.33

2.91

1.5

1.3

152.63

160.13

mmol/24h

0.17

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

4.10

2.88

1.2

1.0

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

102

2.17

2.87

3.6

2.8

40890.91

41136.32

ug/l

0.03

102

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

6.68

2.87

2.5

1.0

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

107

771

1.41

2.84

1.9

1.6

378.25

301.98

mu/l

0.92

100

693

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

4.46

2.79

1.0

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

140

1058

1.34

2.79

1.0

—

(3013293) Extractable nuclear Ab [Presence] in Serum

3.92

2.77

2.6

1.6

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.92

2.77

1.2

1.0

—

(3016244) Insulin [Units/volume] in Serum or Plasma

145

1.94

2.75

3.0

3.3

24.98

23.00

mu/l

0.14

138

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

101

726

1.41

2.73

1.4

1.3

238.30

229.76

miu/ml

0.07

355

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

116

854

1.38

2.73

2.4

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

125

933

1.36

2.70

1.5

1.4

25.21

25.22

iu/l

0.00

111

787

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

2.51

2.70

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

126

943

1.36

2.68

3.0

2.2

1724.83

4685.65

u/l

1.92

374

(3044927) Protein electrophoresis panel - Urine

168

1.86

2.67

1.3

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

3.76

2.67

1.1

1.3

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.36

2.55

1.1

83.43

91.56

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

7.15

2.55

1.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

7.15

2.55

3.0

1.1

—

(3048879) Bone marrow aspiration report

2.87

2.54

1.7

1.6

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1855

17919

1.18

2.54

4.7

4.1

4.60

4.68

mmol/l

2.97

1721

16689

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

187

1.78

2.49

2.1

2.4

—

(3003740) Influenza virus B Ag [Presence] in Specimen

302

1.60

2.48

1.3

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

151

1.86

2.47

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.82

2.46

1.4

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

303

1.60

2.45

1.3

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

2.47

2.45

1.1

1.0

21.78

12.64

u/ml

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

3.13

2.43

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

3.13

2.43

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

3.13

2.43

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

3.13

2.43

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.90

2.41

1.3

1.2

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

2.18

2.41

1.1

97.92

90.71

0.40

(3049717) Cytology report of Urine Cyto stain

567

1.43

2.38

2.1

2.6

—

(3026480) Teichoate Ab [Titer] in Serum

6.26

2.37

1.2

1.0

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.42

2.37

1.1

1.0

—

(3042517) Benzodiazepines panel - Urine

3.65

2.36

3.5

2.7

—

(40765096) Chromosome analysis panel by Banding

2.51

2.36

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

3.04

2.35

1.1

1.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1881

18223

1.17

2.33

5.0

4.5

2.71

2.77

mmol/l

2.24

1735

16862

(3013139) Helicobacter pylori Ag [Presence] in Stool

148

1162

1.29

2.30

1.2

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

2.13

2.28

1.2

36.06

15.36

u/l

1.16

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

4.62

2.27

1.8

6.5

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

524

4674

1.16

2.23

1.7

1.6

1.42

1.35

mmol/l

1.13

430

3934

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

142

1.84

2.23

1.0

259.42

245.90

mg/l

0.11

122

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

2.10

2.22

1.2

120.11

79.75

u/l

1.03

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

257

2158

1.21

2.22

1.5

1.4

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1837

17784

1.16

2.21

4.6

4.0

1.43

1.48

mmol/l

4.45

1693

16469

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

331

2848

1.19

2.21

2.4

2.2

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

150

1.81

2.20

1.2

1.1

40.52

40.77

mg/l

0.01

122

(40758292) HTLV I+II Ab panel - Serum

3.34

2.18

1.4

1.3

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

3.34

2.18

7.3

3.6

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

603

1.39

2.17

4.3

3.3

5762.90

868.11

u/ml

0.46

511

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.25

2.17

1.1

78.33

89.91

—

(3051651) Icteric interference index of Serum or Plasma

108

1.95

2.15

4.0

3.7

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

227

1.64

2.15

1.2

1.3

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

144

1.81

2.14

2.1

1.4

0.70

1.35

promille

1.72

113

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.01

2.14

4.6

7.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.79

2.13

1.6

2.5

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

138

1.82

2.09

1.0

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

276

1.57

2.09

1.3

3.13

5.16

u/ml

0.73

125

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.57

2.08

1.1

1.4

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

5.01

2.07

1.2

1.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.51

2.05

1.3

1.2

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.01

2.04

1.5

1.1

—

(3004775) Volume in Urine collected for unspecified duration

132

1.83

2.03

3.3

2.2

693.59

598.82

0.45

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

467

1.43

2.02

2.5

1.9

7.78

4.75

iu/l

0.81

156

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1168

0.74

2.01

1.2

1.4

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

3.08

2.01

2.1

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

3.08

2.01

2.1

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

3.08

2.01

2.1

1.0

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

111

1.90

2.01

1.1

1.2

1.07

1.04

ratio

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

2.82

2.00

1.7

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

134

1.80

1.95

1.3

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

134

1.80

1.95

1.3

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

134

1.80

1.95

1.3

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

388

1.45

1.93

3.4

2.3

92.55

100.13

ug/min

0.07

240

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.45

1.93

2.0

1.0

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

3.19

1.88

3.0

4.9

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.40

1.85

1.8

2.6

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.40

1.85

1.8

2.6

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

479

4304

1.14

1.83

5.3

4.9

2.53

3.16

ug/l

0.52

418

3836

(3003694) ABO and Rh group [Type] in Blood

607

5541

1.13

1.81

1.6

1.5

—

(40757373) Influenza virus identified in Isolate

2.58

1.80

2.1

1.7

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.58

1.80

2.1

1.2

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

3.05

1.80

1.0

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.17

1.77

3.2

2.4

—

(3008295) Osmolality of Serum or Plasma

185

1.63

1.75

1.6

1.4

281.71

280.86

mosm/kgh2o

0.09

139

(3023410) Appearance of Cerebral spinal fluid

185

1.63

1.75

2.4

2.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

2.03

1.75

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.34

1.74

1.0

1.3

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

2.92

1.72

7.7

3.3

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

3.85

1.71

8.6

3.8

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

3.85

1.71

1.2

1.0

—

(3014051) Protein [Presence] in Urine by Test strip

501

1.37

1.70

2.7

2.4

—

(3051611) Lipemic interference index of Serum or Plasma

179

1.63

1.69

3.4

3.3

—

(21494755) Public health laboratory ask at order entry panel

154

1860

0.82

1.68

1.4

1.3

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

300

1.48

1.68

1.1

—

(3002256) Pathology report gross observation

265

2296

1.17

1.66

1.3

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

668

1.31

1.66

1.8

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

3.16

1.66

1.2

1.1

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

188

1.60

1.66

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

536

0.67

1.65

1.4

1.5

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

595

0.68

1.65

1.5

1.7

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

121

1.74

1.58

1.5

1.6

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

305

1.45

1.56

1.2

1.1

13.18

1706.24

iu/ml

0.54

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

273

1.47

1.54

1.2

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

3.34

1.52

1.0

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.86

1.50

1.2

1.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

275

2416

1.16

1.47

1.9

1.7

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

268

1.46

1.2

1.1

130.39

116.61

1.39

246

(3024869) Neuronal Ab [Presence] in Serum

2.50

1.45

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.50

1.45

1.0

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

2.73

1.43

1.0

—

50.75

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.73

1.43

1.0

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.31

1.43

1.0

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

133

1.66

1.42

1.3

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

133

1.66

1.42

1.3

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

133

1.66

1.42

1.3

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

2.18

1.40

1.6

1.4

8.20

8.62

ug/l

—

(3006462) Nitrate [Presence] in Urine

1.80

1.37

3.4

2.9

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

199

1.51

1.35

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

107

1307

0.81

1.35

1.5

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.04

1.32

1.1

1.5

—

(3011288) Drugs identified in Urine by Screen method

621

1.28

1.32

2.9

3.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

143

1694

0.83

1.32

1.5

1.6

—

(3003434) Protein [Mass/volume] in Pleural fluid

201

1.50

1.30

1.6

1.4

32.13

32.31

g/l

0.02

177

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

137

1.61

1.29

1.0

11.13

12.17

iu/ml

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

293

1.41

1.28

1.1

1.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

2.78

1.28

1.0

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.40

1.24

2.7

2.2

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

2.00

1.23

1.6

1.1

47.27

56.66

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

139

1.59

1.23

1.0

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

116

1.64

1.21

1.0

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

221

1.45

1.21

1.2

1.3

—

nmol/l

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.11

1.18

1.7

1.2

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

165

1.52

1.17

1.7

1.3

20589.67

96092.73

e6/l

0.91

(3025018) Bordetella pertussis Ab [Titer] in Serum

125

1.61

1.17

1.1

1.2

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

2.00

1.16

2.8

5.4

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

2.00

1.16

1.4

2.7

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.50

1.15

1.0

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.50

1.15

4.4

8.6

6.20

6.52

mmol/l

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

726

1.23

1.13

2.3

1.7

4.42

3.31

mg/l

0.81

529

(3024263) Appearance of Synovial fluid

1.75

1.13

1.2

1.4

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

268

1.39

1.10

1.1

1.0

1.36

2.65

u/ml

1.53

125

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

363

1.33

1.10

3.6

2.3

1.15

0.80

nmol/l

1.42

306

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

2.38

1.09

1.0

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.82

1.09

1.7

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

177

1.47

1.07

1.1

1.0

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.69

1.07

1.4

1.1

1554.67

1474.08

miu/ml

0.08

(4146454) Self-monitoring of blood glucose

178

1.47

1.05

2.3

2.7

—

(3027008) Opiates [Presence] in Urine

109

916

1.20

1.05

2.4

2.2

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.28

1.03

1.0

—

(3020491) Glucose [Moles/volume] in Blood

138

1.53

1.03

4.0

1.6

5.80

6.73

mmol/l

0.89

(3015183) Erythrocyte sedimentation rate

106

1.61

1.02

1.4

1.2

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

324

1.33

1.02

1.3

1.4

6.05

4.43

ug/l

0.27

299

(3028300) Cannabinoids [Presence] in Urine

109

919

1.20

1.02

2.4

2.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

375

3447

1.10

1.01

4.3

4.2

22.05

21.54

0.22

192

1634

(3016879) Cocaine [Presence] in Urine

101

847

1.20

1.00

2.5

2.3

—

(3028707) Methadone [Presence] in Urine by Screen method

396

1.29

0.99

2.4

3.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

115

1.57

0.99

2.6

1.7

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.95

0.97

4.9

5.7

—

(3000764) Benzodiazepines [Presence] in Urine

107

909

1.19

0.94

2.4

2.2

—

(3012441) Differential panel - Pleural fluid

158

1.46

0.93

1.7

1.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

708

1.21

0.92

1.6

1.4

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.15

0.91

1.2

1.5

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.15

0.91

2.7

2.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.07

0.89

1.2

1.7

—

(3005570) Glucose [Moles/volume] in Urine

202

1.39

0.89

1.8

2.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

315

1.31

0.88

1.5

0.25

0.38

nmol/l

1.65

253

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.79

0.87

1.9

1.0

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

326

1.29

0.85

3.6

3.2

0.81

nmol/l

0.02

253

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.67

0.85

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

291

1.31

0.85

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

842

0.83

0.84

1.5

1.4

—

(3027944) Amphetamines [Presence] in Urine

105

903

1.17

0.82

2.4

2.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

237

0.67

0.81

1.4

1.6

—

(3017569) Oxygen content in Arterial blood

1.65

0.81

2.7

2.9

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

1.55

0.81

1.8

2.2

61.70

52.50

umol/l

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

642

0.81

1.5

1.6

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

190

1.37

0.79

5.4

4.8

60.73

77.50

u/ml

—

(3051101) Glucose [Moles/volume] in Cord blood

0.00

0.78

0.0

6.4

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

115

1.48

0.76

1.2

1.1

1.01

1.04

u/l

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

536

0.80

0.74

1.4

1.5

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.84

0.73

1.0

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

545

0.80

0.72

1.4

1.5

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

310

0.74

0.71

1.3

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

720

1.17

0.71

2.3

2.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.75

0.71

4.9

5.8

—

(3005033) Fetal Nuchal fold Thickness US

531

0.81

0.69

1.4

1.5

—

(1761482) Bacteria [#/volume] in Urine by Culture

418

1.23

0.69

5.9

4.4

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.85

0.68

1.6

1.4

—

(3020393) Adenovirus Ag [Presence] in Stool

1.79

0.66

1.6

1.3

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.79

0.66

1.6

1.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

363

3405

1.08

0.66

1.6

1.4

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

137

1.39

0.64

1.5

2.4

1.23

2.42

u/field

0.95

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

306

1.25

0.62

1.3

1.2

—

(40768793) Breast Pathology biopsy report

443

1.20

0.62

1.3

—

(3022689) Creatine [Moles/volume] in Urine

1.60

0.61

2.4

1.7

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

130

1.39

0.61

1.8

2.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

113

1.42

0.61

7.5

7.2

—

(3045788) Cell count panel - Pleural fluid

156

1.35

0.61

1.7

1.3

—

(3000330) Specific gravity of Urine by Test strip

101

893

1.14

0.60

4.8

3.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

228

2112

1.09

0.58

1.7

1.8

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.72

0.57

1.5

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.67

0.56

1.5

1.3

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

107

1.40

0.55

1.1

1.0

729.70

696.31

ng/l

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

122

0.65

0.54

1.1

1.5

5.16

5.79

mmol/l

—

116

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.58

0.54

1.0

1.1

—

(40768806) Pleura Pathology biopsy report

161

1.31

0.51

2.0

1.5

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

109

1.38

0.51

1.1

1.0

25.60

47.25

ng/l

—

(3024928) Oxygen saturation in Venous blood

361

1.19

0.50

3.2

3.5

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

306

1.21

0.50

2.2

2.5

7.37

5.84

umol/l

0.18

218

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

266

2500

1.07

0.49

3.3

3.0

0.74

0.77

ug/l

0.21

189

1608

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.45

0.48

1.8

1.6

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

138

1.31

0.45

2.4

1.5

1.00

0.99

g/l

0.06

138

(3023511) Choriogonadotropin [Units/volume] in Urine

506

1.15

0.45

1.4

1.3

—

(3029075) Extractable nuclear Ab panel - Serum

1.40

0.45

1.1

1.0

—

(3035880) pH of Pleural fluid

1.40

0.44

1.3

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.37

0.44

2.1

3.3

—

(3020650) Glucose [Presence] in Urine

1.37

0.44

1.0

1.5

—

(3036180) Methadone [Presence] in Urine

1.36

0.41

2.0

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

105

1.34

0.41

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

195

1.23

0.40

1.1

—

(3034426) Prothrombin time (PT)

1.33

0.40

1.3

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.00

0.40

0.0

2.7

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

1.43

0.39

1.2

1.5

3.20

4.83

nmol/l

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.00

0.39

0.0

8.3

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.35

0.37

2.2

1.6

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

283

1.17

0.34

1.3

1.2

2.18

4.25

u/ml

0.91

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

275

0.83

0.33

1.1

1.4

6.49

7.30

mmol/l

1.28

247

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

656

0.90

0.33

1.5

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

403

0.87

0.33

4.2

3.3

20.50

25.33

mg/l

0.56

252

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

655

0.90

0.32

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

654

0.90

0.32

1.5

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

652

0.90

0.30

1.5

—

(3006653) Thiamine [Moles/volume] in Blood

1.29

0.30

1.4

1.3

146.08

140.79

nmol/l

0.13

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

723

0.91

0.29

1.5

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

324

0.86

0.29

1.6

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

718

1.09

0.28

1.6

1.9

—

(3003338) MCHC [Mass/volume]

1606

16200

0.97

0.25

29.8

16.2

331.72

332.48

g/l

2.58

1592

16070

(1617658) Protocol used for examination of sentinel lymph nodes

159

0.82

0.24

1.0

—

(40768800) Prostate Pathology biopsy report

274

1.13

0.24

1.0

1.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

115

1.22

0.23

1.7

1.3

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

1.28

0.23

1.2

1.0

—

(3036782) Glucose [Moles/volume] in Pleural fluid

153

1.18

0.22

1.5

1.3

7.01

6.66

mmol/l

0.16

143

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.0

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

142

1355

1.05

0.21

2.1

1.9

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

1.23

0.21

1.2

1.3

165.41

168.73

pmol/l

0.02

(3041806) Other cells [#/volume] in Blood by Manual count

114

0.79

0.20

1.9

1.5

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

165

0.85

0.19

1.4

1.6

—

(3035933) Granulocytes/100 leukocytes in Blood

0.75

0.17

1.2

1.4

—

(3035320) C reactive protein [Mass/volume] in Body fluid

141

0.85

0.16

4.6

2.1

—

(4094501) Cardiovascular stress test using bicycle ergometer

432

0.92

0.16

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

369

0.92

0.15

2.1

1.8

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.08

0.14

1.0

—

(1761868) Lipid panel - Serum or Plasma

660

6514

1.02

0.14

3.0

2.6

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.82

0.13

1.3

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

176

1712

1.03

0.13

2.2

2.0

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

143

1.12

0.11

1.5

1.9

—

(3044007) Cell count panel - Peritoneal fluid

1.09

0.09

1.0

2.0

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

1.04

0.09

1.2

1.3

0.60

3.95

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.08

0.08

1.0

1.1

—

(3011648) Oxygen content in Venous blood

147

1.09

0.07

3.8

4.2

11.16

11.18

0.01

147

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1.07

0.07

1.0

1.4

—

(3044242) Glucose [Moles/volume] in Arterial blood

1.06

0.07

3.0

2.6

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.06

0.07

1.0

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

118

1.10

0.07

1.6

1.4

—

(1002224) Polysomnography panel

710

1.03

0.06

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

121

1.07

0.03

1.2

1.5

77.00

79.81

umol/l

0.19

121

(3001019) Free T4 and TSH panel - Serum or Plasma

108

1065

1.01

0.03

1.8

1.7

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

668

1.02

0.03

1.5

—

(4281824) Cell count and differential, peritoneal fluid

202

1.04

0.02

1.2

1.1

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

193

1.04

0.01

1.3

1.6

7.42

7.65

mmol/l

0.20

188

(3022621) pH of Urine by Test strip

123

1238

0.99

0.01

2.7

2.8

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

116

0.95

0.00

1.1

1.4

1.60

1.57

g/l

0.17

116

(3033705) Calcium.ionized [Moles/volume] in Venous blood

186

0.97

0.00

4.3

2.4

—

(3025130) Human papilloma virus identified in Specimen

288

1.01

0.00

1.4

1.8

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

137

1.02

0.00

1.6

1.5

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

-0.00

0.0

7.3

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

-0.00

0.0

1.0

—

36.46

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

-0.00

0.0

1.0

—

71.80

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

0.00

-0.00

0.0

1.0

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

-0.00

0.0

1.0

—

382.60

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.00

-0.00

0.0

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

0.92

-0.00

4.3

1.3

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

2.0

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

5.8

—

0.24

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.2

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

0.96

-0.00

2.7

1.8

145.00

153.26

nmol/l

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

1.00

-0.00

1.2

1.3

45.67

58.69

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.6

—

(3022475) Manganese [Moles/volume] in Blood

0.00

-0.00

0.0

1.6

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3051593) INR in Capillary blood by Coagulation assay

0.92

-0.00

1.3

15.4

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(3022670) pH of Venous cord blood

0.00

-0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

-0.00

0.0

1.1

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: L12_INTERNALSUBSTANCEDERM – Dermatitis due to substances taken internally

GWS hits: 1

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Dermatitis due to substances taken internally

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Dermatitis due to substances taken internally (L12_INTERNALSUBSTANCEDERM)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints